As Filed with the Securities and Exchange Commission on May 14, 2002.
Registration No. 333-82872
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
Amendment No. 1
to
FORM S-3
REGISTRATION STATEMENT
Under the Securities Act of 1933
--------------------
RITE AID CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware 5912 23-1614034
(State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer
Incorporation or Organization) Classification Code Number) Identification Number)
--------------------
30 Hunter Lane
Camp Hill, Pennsylvania 17011
(717) 761-2633
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of Registrant's Principal Executive Offices)
--------------------
Elliot S. Gerson, Esq.
Senior Executive Vice President and General Counsel
Rite Aid Corporation
30 Hunter Lane
Camp Hill, Pennsylvania 17011
(717) 761-2633
(717) 760-7867 (facsimile)
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
--------------------
Copy to:
Stacy J. Kanter, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times Square
New York, New York 10036
(212) 735-3000
(212) 735-2000 (facsimile)
--------------------
Approximate date of commencement of proposed sale to the public: As soon as
practicable after the effective date of this Registration Statement.
If the only securities being registered on this Form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. |_|
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered in connection with dividend or reinvestment
plans, please check the following box. |X|
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. |_|
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. |_|
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. |_|
--------------------
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
===============================================================================
Subject to completion, dated May 14, 2002
PROSPECTUS
$250,000,000
RITE AID CORPORATION
4.75% Convertible Notes due 2006 and
38,461,539 Shares of Common Stock
Issuable upon Conversion of the Notes
This prospectus relates to the offer and sale from time to time by the
selling security holders named herein, including their respective transferors,
donees, pledgees or successors, of up to $250,000,000 principal amount of our
4.75% Convertible Notes due 2006 and the shares of our common stock issuable on
conversion of the notes.
The prices at which the selling security holders may sell the notes and the
shares will be determined by prevailing market prices or through privately
negotiated transactions. We will not receive any proceeds from the sale of any
of the notes or the shares. We have agreed to bear the expenses of registering
the notes and shares covered by this prospectus under federal and state
securities laws.
The notes and shares are being registered to permit the selling security
holders to sell the notes and the shares from time to time in the public market.
The selling security holders may sell the notes and shares through ordinary
brokerage transactions or through any other means described in the section
titled "Plan of Distribution." We do not know when or in what amount the selling
security holders may offer notes and shares for sale. The selling security
holders may sell any, all or none of the notes and shares offered by this
prospectus.
Interest on the notes is payable on June 1 and December 1 of each year,
beginning on June 1, 2002. The notes are convertible by holders into shares of
our common stock at a conversion price of $6.50 per share (subject to adjustment
in certain events) at any time following issuance of the notes, unless we
previously have redeemed or repurchased the notes or unless the notes previously
have matured. Our common stock is listed on the New York Stock Exchange and the
Pacific Exchange under the symbol "RAD." The last reported price of our common
stock on the NYSE on May 13, 2002 was $3.01 per share.
The notes will mature on December 1, 2006. We may redeem some or all of the
notes at any time on or after December 5, 2004, at the redemption prices
specified under the caption "Description of Notes--Optional Redemption" plus
accrued interest and liquidated damages, if any, to the redemption date if the
market price of our common stock equals or exceeds 125% of the conversion price
for a specified period.
The notes are unsubordinated, unsecured obligations of Rite Aid Corporation
and rank equally in right of payment to all of our other unsubordinated,
unsecured indebtedness. Our subsidiaries own substantially all of our operating
assets, and the notes are effectively subordinated to all indebtedness of our
subsidiaries. Under certain circumstances, holders of the notes have the right
to require us to repurchase the notes at the prices described in this
prospectus.
See "Risk Factors" beginning on page 10 for a discussion of risks you should
consider before investing in our securities.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a
criminal offense.
The date of this prospectus is , 2002
The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell these securities and we are not soliciting an offer to buy these
securities in any state where the offer or sale is not permitted.
TABLE OF CONTENTS
Page
----
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS .................... 1
WHERE YOU CAN FIND MORE INFORMATION ..................................... 2
INCORPORATION BY REFERENCE .............................................. 2
PROSPECTUS SUMMARY ...................................................... 3
THE OFFERING ............................................................ 7
RISK FACTORS ............................................................ 10
USE OF PROCEEDS ......................................................... 18
RATIO OF EARNINGS TO FIXED CHARGES ...................................... 18
SELLING SECURITY HOLDERS ................................................ 19
DESCRIPTION OF NOTES .................................................... 22
DESCRIPTION OF CAPITAL STOCK ............................................ 35
CERTAIN UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS ................. 39
PLAN OF DISTRIBUTION .................................................... 43
LEGAL MATTERS ........................................................... 45
EXPERTS ................................................................. 45
CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS
This prospectus includes forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements are identified by terms and phrases such as "anticipate," "believe,"
"intend," "estimate," "expect," "continue," "should," "could," "may," "plan,"
"project," "predict," "will," and similar expressions and include references to
assumptions and relate to our future prospects, developments and business
strategies.
Factors that could cause our actual results to differ materially from those
expressed or implied in such forward-looking statements include, but are not
limited to:
o our high level of indebtedness;
o our ability to make interest and principal payments on our debt and satisfy
the other covenants contained in our credit facilities and other debt
agreements;
o our ability to improve the operating performance of our existing stores,
and, in particular, our new and relocated stores in accordance with our
management's long-term strategy;
o the outcomes of pending lawsuits and governmental investigations, both
civil and criminal, involving our financial reporting and other matters;
o competitive pricing pressures and continued consolidation of the
drugstore industry;
o third-party prescription reimbursement levels and regulatory changes
governing pharmacy practices;
o general economic conditions, inflation and interest rate movements;
o merchandise supply constraints or disruptions; and
o access to capital.
We undertake no obligation to revise the forward-looking statements included
in this prospectus to reflect any future events or circumstances. Our actual
results, performance or achievements could differ materially from the results
expressed in, or implied by, these forward-looking statements. Factors that
could cause or contribute to such differences are discussed in this prospectus
in the section titled "Risk Factors."
1
WHERE YOU CAN FIND MORE INFORMATION
We are subject to the informational requirements of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"). Accordingly, we file annual,
quarterly and current reports, proxy statements and other information with the
SEC. We also furnish to our security holders annual reports, which include
financial statements audited by our independent certified public accountants and
other reports which the law requires us to send to our security holders. The
public may read and copy any reports, proxy statements or other information that
we file at the SEC's public reference room at Judiciary Plaza, 450 Fifth Street,
N.W., Washington, D.C. 20549 and at the SEC's regional office at 505 West
Madison Street, Suite 1400, Chicago, Illinois 60661. The public may obtain
information on the public reference room by calling the SEC at 1-800-SEC-0330.
Our SEC filings are also available to the public from commercial document
retrieval services and at the Web site maintained by the SEC at
"http://www.sec.gov."
Our common stock is listed on the New York Stock Exchange and the Pacific
Exchange under the symbol "RAD." You can inspect and copy reports, proxy
statements and other information about us at the NYSE's offices at 20 Broad
Street, New York, New York 10005 and at the Pacific Exchange's offices at 301
Pine Street, San Francisco, California 94104.
This is a registration statement on Form S-3 under the Securities Act of
1933, as amended (the "Securities Act") covering our convertible notes due 2006
and the shares of our common stock issuable on conversion of the notes offered
by this prospectus. This prospectus does not contain all of the information in
the registration statement. You will find more information about us and our
common stock in the registration statement. In addition, certain information in
the registration statement has been omitted from the prospectus in accordance
with the rules of the SEC. Any statements made in this prospectus concerning the
provisions of legal documents are not necessarily complete and you should read
the documents which are filed as exhibits to the registration statement or
otherwise filed with the SEC.
INCORPORATION BY REFERENCE
The SEC allows us to incorporate by reference the information in documents we
file with the SEC, which means that we can disclose important information to you
by referring to those documents. The information incorporated by reference is
considered to be a part of this prospectus, and information that we file later
with the SEC will automatically update and supersede the information in this
prospectus. We incorporate by reference the documents listed below and any
future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of
the Exchange Act until the Selling Security holders sell all of the shares
offered by this prospectus:
o Our Annual Report on Form 10-K, for the fiscal year ended March 2, 2002,
filed on May 7, 2002; and
o The description of our common stock contained in our Registration Statement
on Form 8-A filed under the Exchange Act.
You may request a copy of any of these filings, at no cost, by writing or
telephoning us at the following address:
Rite Aid Corporation
30 Hunter Lane
Camp Hill, Pennsylvania 17011
Attention: General Counsel
Phone: (717) 761-2633
2
PROSPECTUS SUMMARY
The following information summarizes the detailed information and financial
statements included elsewhere or incorporated by reference in this prospectus.
We encourage you to read this entire prospectus carefully. Unless otherwise
indicated or the context otherwise requires, dates in this prospectus that refer
to a particular fiscal year (e.g., fiscal 2002) refer to the fiscal year ended
on the Saturday closest to February 29 or March 1 of that year. The fiscal year
ended March 3, 2001 included 53 weeks. The fiscal years ended March 2, 2002,
February 26, 2000, February 27, 1999 and February 28, 1998 included 52 weeks.
Rite Aid Corporation
Our Business
We are the third largest retail drugstore chain in the United States. We
operate 3,497 drugstores in 28 states and in the District of Columbia. During
fiscal 2002, we generated $15.2 billion in revenues. Since the beginning of
fiscal 1997, we have acquired 1,564 stores, relocated 967 stores, built 473 new
stores and remodeled 470 stores. As a result, we believe we have one of the
most modern store bases in the industry.
In our stores, we sell prescription drugs and a wide assortment of other
merchandise, which we call "front-end" products. In fiscal 2002, our
pharmacists filled more than 202 million prescriptions, which accounted for
61.3% of our total sales. We believe that our pharmacy operations will continue
to represent a significant part of our business due to favorable industry
trends, including an aging population, increased life expectancy and the
discovery of new and better drug therapies. We offer approximately 24,700
different types of front-end products, including over-the-counter medications,
health and beauty aids, personal care items, cosmetics, household items,
beverages, convenience foods, greeting cards, photo processing, seasonal
merchandise and numerous other everyday and convenience products, which
accounted for the remaining 38.7% of our total sales in fiscal 2002. We
distinguish our stores from other national chain drugstores, in part, through
our private brands and our strategic alliance with General Nutrition Companies,
Inc. ("GNC"), a leading retailer of vitamin and mineral supplements. We offer
approximately 1,700 products under the Rite Aid private brand, which contributed
approximately 10.6% of our front-end sales in fiscal 2002.
Background
Under prior management, we were engaged in an aggressive expansion program
from the beginning of fiscal 1997 until December 1999. During that period, we
purchased 1,554 stores, relocated 866 stores, opened 445 new stores, remodeled
308 stores and acquired PCS Health Systems, Inc. These activities had a
significant negative impact on our operating results and financial condition,
severely strained our liquidity and increased our indebtedness, including lease
financing obligations, to $6.6 billion as of February 26, 2000, which
contributed to our inability to access the financial markets. A resulting
decrease in revenue due to inventory shortages, reduction in advertising and
uncompetitive prices on front-end products led to a decline in customer traffic,
which had a negative impact on our store operations. In October 1999, we
announced that we had identified accounting irregularities and our former
chairman and chief executive officer resigned. In November 1999, our former
auditors resigned and withdrew their previously issued opinions on our financial
statements for fiscal 1998 and fiscal 1999. We needed to restate our financial
statements and develop accounting systems and controls that would allow us to
manage our business and accurately report the results of our operations.
In December 1999, a new management team was hired, and since that time we
have been addressing our business, operational and financial challenges. In
response to our situation, new management has:
o Reduced our indebtedness, including lease financing obligations, from $6.6
billion as of February 26, 2000 to $4.1 billion as of March 2, 2002;
3
o Improved our front-end same store sales growth from a negative 2.2% in
fiscal 2000 to a positive 3.6% during fiscal 2002 by improving store
conditions and product pricing and launching a competitive marketing
program;
o Restated our financial statements for fiscal 1998 and fiscal 1999, as well
as engaged Deloitte & Touche LLP as our new auditors to audit our
financial statements for fiscal 1998, fiscal 1999 and fiscal 2000;
o Settled the securities class action and related lawsuits in February 2002
for $45.0 million funded with insurance proceeds and $149.5 million of
senior secured notes, issued in April 2002 and due March 15. 2006;
o Addressed out-of-stock inventory levels and strengthened our vendor
relationships;
o Implemented initiatives to improve all aspects of our supply chain,
including buying practices, category management systems and other
inventory issues;
o Addressed and corrected problems with our accounting systems and controls,
and resumed normal financial reporting; and
o Completed the refinancing of our indebtedness.
Our Strengths
We believe that we are well-positioned to build on the significant investment
in our modern store base by capitalizing on our competitive strengths, including
the following:
Strong Brand Name with Leading Shares in Key Markets
o We are the nation's third largest drugstore chain with 3,497 stores.
o Our stores are primarily located in convenient locations within fast
growing metropolitan markets.
o We believe that our brand name has helped us establish a large group of
loyal customers.
New Management Team Leading Operational Turnaround
o We improved front-end same store sales growth from a negative 2.2% in
fiscal 2000 to a positive 3.6% in fiscal 2002 by improving store
conditions and product pricing and launching a competitive marketing
program.
o We curtailed our expansion plans and reduced our capital expenditures from
$573.3 million in fiscal 2000 to $132.5 million in fiscal 2001 and $175.2
million in fiscal 2002.
Modern Store Base
o Since the beginning of fiscal 1997, we built 473 new stores, relocated 967
stores, remodeled 470 stores and closed 1,307 stores, providing us with
what we believe to be one of the most modern store bases in the industry.
o Most of our new stores are based on our prototype and typically include a
drive-thru pharmacy and a one-hour photo shop. Many of our stores include
a GNC store-within-Rite Aid-store.
o To support these new stores, we have improved our distribution network by
opening two high capacity distribution centers.
Compelling Industry Fundamentals and Demographic Trends
o According to IMS Health Incorporated, an independent industry source, the
retail prescription drug industry is expected to be one of the fastest
growing retail segments in the U.S. over the next ten years.
o Increasing life expectancy and the "baby boom" generation entering their
fifties are expected to drive pharmacy sales which we estimate to increase
75% over the next five years.
o Several factors will contribute to this continued growth in the pharmacy
sector, including a record number of drugs in the FDA approval pipeline.
4
Our Business Strategy
Our primary long-term operating strategy is to continue to focus on improving
the productivity of our existing store base. We believe that improving the sales
of our existing stores is important to achieving profitability and improving
cash flow. To achieve this objective, we are implementing the following
strategies:
Capitalize on Investments in Stores and Distribution Facilities
o Attract new customers to our modern stores through various marketing
strategies including weekly circulars, seasonal merchandising programs and
direct marketing efforts;
o Implement programs that are specifically directed towards our pharmacy
business, including reducing cash prices and enhancing our proprietary
inventory replenishment system; and
o Leverage our modern distribution facilities by utilizing new category
management tools and implementing item level productivity analysis.
Improve Product Offerings in our Stores
o Continue to add popular product departments, such as our GNC
stores-within-Rite Aid-stores and one-hour photo services;
o Improve inventory and product categories to offer more personalized
products and services to our customers, including better management of
seasonal items;
o Increase both private brand front-end products and generic prescription
drugs to improve margins; and
o Strengthen our relationships with our suppliers in order to offer
customers a wider selection of products.
Enhance Customer and Associate Relationships
o Enhance positive perceptions among customers through vendor promotions and
weekly sales items;
o Improve customer loyalty by establishing a strong community presence,
increasing promotional themes and exclusive offers, and focusing on the
attraction and retention of managed care customers; and
o Develop associate programs that create compensatory and other incentives
for associates to provide customers with quality service and to improve
our corporate culture.
Refinancing
On June 27, 2001, we completed a comprehensive refinancing (the
"Refinancing") that included a new $1.9 billion senior secured credit facility
underwritten by Citicorp North America, Inc., The Chase Manhattan Bank, Credit
Suisse First Boston and Fleet Retail Finance, Inc. As a result of the
Refinancing, we have significantly reduced our debt and the amount of our debt
maturing prior to March 2005.
Simultaneously with or prior to the closing of the new credit facility, we
completed the following transactions, which also formed part of the Refinancing:
o $552.0 million in private placements of our common stock.
o An exchange with a financial institution of $152.0 million of our 10.5%
senior secured notes due 2002 for $152.0 million of new 12.5% senior
secured notes due 2006. The 12.5% senior secured notes due 2006 are secured
by a second lien on the collateral securing the new credit facility.
o Private exchanges of common stock for $303.5 million of our bank debt and
10.5% senior secured notes due 2002.
5
o A synthetic lease transaction with respect to two of our distribution
centers in the amount of approximately $106.9 million.
o $150 million in a private placement of new 11.25% senior notes due 2008.
o The reclassification of $850.8 million of capital leases as operating
leases.
o An operating lease that we entered into with respect to our aircraft for
approximately $25.6 million.
o A tender offer whereby we accepted for payment $174.5 million of our 10.5%
senior secured notes due 2002 at 103.25% of their principal amount.
With the proceeds of the Refinancing, we repaid our previous senior secured
credit facility, our PCS and RCF credit facilities, and our secured exchange
debt. As a result of the Refinancing, as of March 2, 2002, our remaining debt
due before March 2005 consists of $150.5 million of our 5.25% convertible
subordinated notes due 2002, $20.9 million of our 10.5% senior secured notes due
2002, $83.6 million of our 6% dealer remarketable securities due 2003 and
amortization of the new credit facility.
6
THE OFFERING
Securities Covered by this...... $250,000,000 principal amount of 4.75%
Prospectus Convertible Notes due December 1, 2006, with
interest payable on June 1 and December 1,
commencing on June 1, 2002 and the shares of
common stock issuable upon conversion of such
notes.
Issuer.......................... Rite Aid Corporation, a Delaware corporation.
Ranking......................... The notes are:
o unsubordinated, unsecured obligations; and
o equal in ranking with all of our existing
and future unsubordinated, unsecured debt.
Our subsidiaries conduct substantially all our
operations and have significant liabilities,
including trade payables. The notes are
structurally subordinated to our substantial
subsidiary liabilities, which include
guarantees of our secured debt. In addition,
the notes are effectively subordinated to any
secured debt of Rite Aid Corporation issued in
the future.
As of March 2, 2002:
o our and our subsidiaries' total outstanding
debt was approximately $4.1 billion;
o none of our debt, other than an aggregate of
$150.5 million of our existing 5.25%
convertible subordinated notes dues 2002,
would have been subordinated to the notes;
and
o the total of our outstanding debt (excluding
lease financing obligations) that would be
effectively senior to the notes would have
been approximately $1.7 billion, but we would
have a right to increase this debt
significantly.
The indenture under which the notes have been
issued contains no limitation on the incurrence
of indebtedness and other liabilities by us and
our subsidiaries. See "Description of
Notes--Ranking" and "Risk Factors--Since the
notes are effectively subordinated to all of
our secured debt and the liabilities of our
subsidiaries, we may not have sufficient assets
to pay amounts owed on the notes if a default
occurs."
Conversion Rights............... The notes are convertible at a rate of 153.846
shares of our common stock, par value $1.00 per
share, per $1,000 principal amount of notes
(equivalent to a conversion price of $6.50 per
share), subject to adjustment in certain
events.
The notes are convertible into shares of common
stock at any time, unless we previously have
redeemed or repurchased the notes or unless
the notes previously have matured. Holders
of notes called for redemption
7
or repurchase are entitled to convert their
notes to and including, but not after, the
close of business on the date fixed for
redemption or repurchase, as the case may
be.
Form and Denomination........... The notes covered by this prospectus have been
issued only in registered form. The notes have
been issued in minimum denominations of
$1,000. The notes initially sold by the
initial purchasers are represented by a single
permanent global note in fully registered
form, deposited with a custodian for and
registered in the name of a nominee of The
Depository Trust Company ("DTC"). The notes
sold under this prospectus will be represented
by a new unrestricted global security.
Beneficial interests in the global note will
be shown on, and transfers thereof will be
effected only through, records maintained by
DTC and its participants. Except as described
herein, notes in certificated form will not be
issued in exchange for the global notes or
interests therein. See "Description of Notes--
Book-Entry; Delivery and Form; Global Note."
Optional Redemption............. We may redeem some or all of the notes at any
time after December 5, 2004 at the redemption
prices specified under the caption
"Description of Notes--Optional Redemption"
plus accrued interest and liquidated damages,
if any, to the redemption date if the market
price of our common stock equals or exceeds
125% of the conversion price for a specified
period. See "Description of Notes--Optional
Redemption."
Repurchase at Option of Holders
Upon a Change in Control....... In the event of a Change in Control (as
defined under "Description of Notes--Repurchase
at Option of Holders Upon a Change in Control")
each holder of notes may require us to
repurchase its notes in whole or in part, at a
repurchase price of 100% of the principal
amount thereof, plus accrued interest and
liquidated damages, if any, to the repurchase
date. See "Description of Notes--Repurchase at
Option of Holders Upon a Change in Control" and
"Risk Factors--We may be unable to purchase the
notes upon a change of control."
Events of Default............... Events of default include: (a) failure to pay
any interest (including liquidated damages, as
described under "Description of Notes--
Registration Rights") on any note or coupon
when due, continuing for 30 days; (b) failure
to pay the principal or Redemption Price or
Repurchase Price of any note when due; (c)
default in our obligation to provide notice of
a Change in Control; (d) failure to perform any
other covenant or warranty we make in the
Indenture, continuing for 60 days after written
notice to us as provided in the Indenture;
(e) default under any bond, debenture, note or
other evidence of our Indebtedness or under any
mortgage,
8
indenture or instrument under which there may
be issued or by which there may be secured or
evidenced any of our Indebtedness (including
the notes), which default shall constitute a
failure to pay an aggregate principal amount
exceeding $35,000,000 of such Indebtedness when
due and payable (after the expiration of any
applicable grace period) and shall have
resulted in such Indebtedness becoming or being
declared due and payable prior to the date on
which it would otherwise have become due and
payable, without such Indebtedness having been
discharged, or such acceleration having been
rescinded or annulled, and within a period of
10 days written notice (a Notice of Default) is
given as provided in the Indenture, unless
remedied, cured or waived as provided in the
Indenture; and (f) certain events of
bankruptcy, insolvency or reorganization.
Listing......................... The notes are not listed on an exchange and we
do not intend to apply to have the notes
listed on any exchange. Our common stock is
quoted on the New York Stock Exchange and the
Pacific Exchange under the symbol "RAD."
Use of Proceeds................. We will not receive any of the proceeds of
sales of any of the securities covered by this
prospectus by the selling security holders.
Risk Factors.................... Prospective purchasers of the securities
offered by this prospectus should carefully
consider the information set forth under the
heading "Risk Factors," together with all
information in this prospectus, including the
information we are incorporating by reference,
before making an investment decision in the
securities offered by this prospectus.
Our headquarters are located at 30 Hunter Lane, Camp Hill, Pennsylvania
17011, and our telephone number is (717) 761-2633. The address of our Web site
is "www.riteaid.com." The information on our Web site is not a part of this
prospectus. We were incorporated in 1968 and are a Delaware corporation.
9
RISK FACTORS
An investment in the notes or common stock involves a number of risks. You
should consider carefully the following information about these risks, together
with the other information included and incorporated by reference in this
prospectus, before buying notes or common stock. Additional risks and
uncertainties not presently known to us, or that we currently deem immaterial,
may also impair our business operations. We cannot assure you that any of the
events discussed in the risks factors below will not occur. If they do, our
business, financial condition or results of operations could be materially and
adversely affected. In such case, the trading price of our securities could
decline, and you might lose all or part of your investment.
Risks Related to Our Financial Condition
We are highly leveraged. Our substantial indebtedness will severely limit cash
flow available for our operations and could adversely affect our ability to
service debt or obtain additional financing if necessary.
We had, as of March 2, 2002, $4.1 billion of outstanding indebtedness,
including lease financing obligations, and stockholders' equity of $9.6 million.
We also had additional borrowing capacity under our new revolving credit
facility of $438.7 million at that time, net of outstanding letters of credit of
$61.3 million. Our debt obligations adversely affect our operations in a number
of ways and our cash flow from operations is insufficient to service our debt,
which may require us to borrow additional funds for that purpose, restructure or
otherwise refinance that debt. Our earnings were insufficient to cover our fixed
charges for fiscal 2002 by $761.6 million.
Our high level of indebtedness will continue to restrict our operations.
Among other things, our indebtedness will:
o limit our ability to obtain additional financing;
o limit our flexibility in planning for, or reacting to, changes in the
markets in which we compete;
o place us at a competitive disadvantage relative to our competitors with
less indebtedness;
o render us more vulnerable to general adverse economic and industry
conditions; and
o require us to dedicate substantially all our cash flow to service our
debt.
In fiscal 2000, we experienced operational and financial difficulties,
resulting in disputes with suppliers and vendors. These disputes were based
primarily on our level of indebtedness and led to more restrictive vendor
contract terms. Although we believe that our prior disputes with suppliers and
vendors have been largely resolved, any future material deterioration in our
operational or our financial situation could again impact vendors' and
suppliers' willingness to do business with us. Our ability to make payments on
our debt depends upon our ability to substantially improve our future operating
performance, which is subject to general economic and competitive conditions and
to financial, business and other factors, many of which we cannot control. If
our cash flow from our operating activities is insufficient, we may take certain
actions, including delaying or reducing capital or other expenditures,
attempting to restructure or refinance our debt, selling assets or operations or
seeking additional equity capital. We may be unable to take any of these actions
on satisfactory terms or in a timely manner. Further, any of these actions may
not be sufficient to allow us to service our debt obligations or may have an
adverse impact on our business. Our existing debt agreements limit our ability
to take certain of these actions. Our failure to earn enough to pay our debts or
to successfully undertake any of these actions could have a material adverse
effect on us.
In 2005, a substantial amount of our indebtedness will mature, including the
debt outstanding under our senior secured credit facility.
10
Some of our debt, including borrowings under our new credit facility, is based
upon variable rates of interest, which could result in higher interest expense
in the event of increases in interest rates.
Approximately $528.0 million of our outstanding indebtedness as of March
2, 2002 bears an interest rate that varies depending upon LIBOR and is not
covered by interest rate swap contracts. If we borrow additional amounts under
our senior secured facility, the interest rate on those borrowings will vary
depending upon LIBOR. If LIBOR rises, the interest rates on this outstanding
debt will also increase. Therefore an increase in LIBOR would increase our
interest payment obligations under these outstanding loans and have a negative
effect on our cash flow and financial condition.
The covenants in our outstanding indebtedness impose restrictions that may limit
our operating and financial flexibility.
The covenants in the instruments that govern our outstanding indebtedness
restrict our ability to:
o incur liens and debt;
o pay dividends;
o make redemptions and repurchases of capital stock;
o make loans, investments and capital expenditures;
o prepay, redeem or repurchase debt;
o engage in mergers, consolidations, assets dispositions, sale-leaseback
transactions and affiliate transactions;
o change our business;
o amend certain debt and other material agreements;
o issue and sell capital stock of subsidiaries;
o restrict distributions from subsidiaries; and
o grant negative pledges to other creditors.
Moreover, if we are unable to meet the terms of the financial covenants or if
we breach any of these covenants, a default could result under one or more of
these agreements. A default, if not waived by our lenders, could result in the
acceleration of our outstanding indebtedness and cause our debt to become
immediately due and payable. If acceleration occurs, we would not be able to
repay our debt and it is unlikely that we would be able to borrow sufficient
additional funds to refinance such debt. Even if new financing is made available
to us, it may not be available on terms acceptable to us.
If we obtain modifications of our agreements or are required to obtain
waivers of defaults, we may incur significant fees and transaction costs. In
fiscal 2002 and 2001, we modified certain covenants contined in our senior
credit and loan agreements. In fiscal 2000, we obtained waivers of compliance
with, and modifications to, certain of the covenants contained in our credit
facilities and public indentures. In connection with obtaining these waivers
and modifications, we paid significant fees and transaction costs.
Risks Related to Our Operations
Major lawsuits have been brought against us and certain of our subsidiaries, and
there are currently pending both civil and criminal investigations by the U.S.
Securities and Exchange Commission, the United States Attorney and an
investigation by the United States Department of Labor. In addition to any fines
or damages that we might have to pay, any criminal conviction against us may
result in the loss of licenses and contracts that are material to the conduct of
our business, which would have a negative effect on our results of operations,
financial condition or cash flows.
There are several major ongoing lawsuits and investigations in which we are
involved. These include, in addition to the investigations described below,
several class action lawsuits. While some of these lawsuits have been settled,
pending court approval or appeal, we are unable to predict the outcome of any of
these
11
matters at this time. If any of these cases result in a substantial monetary
judgment against us or are settled on unfavorable terms, our results of
operations, financial condition or cash flows could be materially adversely
affected.
There are currently pending both civil and criminal governmental
investigations by the SEC and the United States Attorney concerning our
financial reporting and other matters. In addition, an investigation has also
been commenced by the U.S. Department of Labor concerning our associate benefit
plans, including our principal 401(k) plan, which permitted associates to
purchase our common stock. Purchases of our common stock under the plan were
suspended in October 1999. In January 2001, we appointed an independent trustee
to represent the interests of these plans in relation to the company and to
investigate possible claims the plans may have against us. Both the independent
trustee and the U.S. Department of Labor have asserted that the plans may have
claims against us. These investigations are ongoing and we cannot predict their
outcomes. If we were convicted of any crime, certain licenses and government
contracts, such as Medicaid plan reimbursement agreements, that are material to
our operations may be revoked, which would have a material adverse effect on our
results of operations and financial condition. In addition, substantial
penalties, damages, or other monetary remedies assessed against us could also
have a material adverse effect on our results of operations, financial condition
or cash flows.
Given the size and nature of our business, we are subject from time to time
to various lawsuits which, depending on their outcome, may have a negative
impact on our results of operations, financial condition or cash flows.
We are substantially dependent on a single supplier of pharmaceutical products
to sell products to us on satisfactory terms. A disruption in this relationship
would have a negative effect on our results of operations, financial condition
or cash flows.
We obtain approximately 93% of our pharmaceutical products from a single
supplier, McKesson HBOC, Inc., pursuant to a long-term contract. Pharmacy sales
represented approximately 61.3% of our total sales during fiscal 2002, and,
therefore, our relationship with McKesson HBOC is important to us. Any
significant disruptions in our relationship with McKesson HBOC would make it
difficult for us to continue to operate our business, and would have a material
adverse effect on our results of operations, financial condition or cash flows.
12
We need to continue to improve our operations in order to improve our financial
condition, but our operations will not improve if we cannot continue to
effectively implement our business strategy or if they are negatively affected
by general economic conditions.
Our operations during fiscal 2000 were adversely affected by a number of
factors, including our financial difficulties, inventory shortages, allegations
of violations of the law, including drug pricing issues, disputes with suppliers
and uncertainties regarding our ability to produce audited financial statements.
To improve operations, new management developed, and in fiscal 2001 began
implementing and continues to implement, a business strategy to improve our
stores and enhance our relationships with our customers by improving the pricing
of products, providing more consistent advertising through weekly circulars,
eliminating inventory shortages and outdated inventory, resolving issues and
disputes with our vendors, developing programs intended to provide better
customer service and purchasing prescription files, and by other means. If we
are not successful in implementing our business strategy, or if our business
strategy is not effective, we may not be able to continue to improve our
operations. In addition, any adverse change in general economic conditions may
adversely affect consumer buying practices and reduce our sales of front-end
products, which are our higher margin products, and cause a proportionately
greater decrease in our profitability. Failure to continue to improve operations
or a decline in general economic conditions would adversely affect our results
of operations, financial condition or cash flows and our ability to make
principal or interest payments on our debt.
We cannot assure you that management will be able to successfully manage our
business or successfully implement our strategic plan. This could have a
material adverse effect on our business and the results of our operations,
financial condition and cash flows.
We cannot assure you that our management will be able to successfully manage
our business or successfully implement our strategic business plan. This could
have a material adverse effect on our results of operations, financial condition
and cash flows.
We are dependent on our management team, and the loss of their services could
have a material adverse effect on our business and the results of our operations
or financial condition.
The success of our business is materially dependent upon the continued
services of our executive management team. The loss of key personnel could have
a material adverse effect on the results of our operations, financial condition
or cash flows. Additionally, we cannot assure you that we will be able to
attract or retain other skilled personnel in the future.
Terrorist attacks, such as the attacks that occurred in New York and Washington,
D.C. on September 11, 2001, and other attacks or acts of war may adversely
affect the markets in which we operate, our operations and our profitability.
On September 11, 2001, the United States was the target of terrorist attacks
of unprecedented scope. These attacks have caused major instability in the U.S.
and other financial markets and reduced consumer confidence. The threat of
terrorist attacks, any military response and other related developments may
adversely affect prevailing economic conditions, resulting in reduced consumer
spending and reduced sales in our stores. These developments will subject us to
increased risks and, depending on their magnitude, could have a material adverse
effect on our business.
13
Risks Related to Our Industry
The markets in which we operate are very competitive and further increases in
competition could adversely affect us.
We face intense competition with local, regional and national companies,
including other drugstore chains, independently owned drugstores, supermarkets,
mass merchandisers, discount stores and mail order pharmacies. We may not be
able to effectively compete against them because our existing or potential
competitors may have financial and other resources that are superior to ours. In
addition, we may be at a competitive disadvantage because we are more highly
leveraged than our competitors. Because many of our stores are new, their
ability to achieve profitability depends on their ability to achieve a critical
mass of customers. While customer growth is often achieved through purchases of
prescription files from existing pharmacies, our ability to achieve this
critical mass through purchases of prescription files could be confined by
liquidity constraints. Although in the recent past, our competitiveness has been
adversely affected by problems with inventory shortages, uncompetitive pricing
and customer service, we have taken steps to address these issues. We believe
that the continued consolidation of the drugstore industry will further increase
competitive pressures in the industry. As competition increases, a significant
increase in general pricing pressures could occur which would require us to
increase our sales volume and to sell higher margin products and services in
order to remain competitive. We cannot assure you that we will be able to
continue effectively to compete in our markets or increase our sales volume in
response to further increased competition.
Changes in third-party reimbursement levels for prescription drugs could reduce
our margins and have a material adverse effect on our business.
Sales of prescription drugs, as a percentage of sales, and the percentage of
prescription sales reimbursed by third parties, have been increasing and we
expect them to continue to increase. In fiscal 2002, sales of prescription drugs
represented 61.3% of our sales and we were reimbursed by third-party payors for
approximately 92.0% of all of the prescription drugs that we sold. During fiscal
2002, the top five third-party payors accounted for approximately 20.0% of our
total sales. Any significant loss of third-party provider business could have a
material adverse effect on our business and results of operations. Also, these
third-party payors could reduce the levels at which they will reimburse us for
the prescription drugs that we provide to their members. Furthermore, if
Medicare is reformed to include prescription benefits, we may be reimbursed for
some prescription drugs at prices lower than our current retail prices. If
third-party payors reduce their reimbursement levels or if Medicare covers
prescription drugs at reimbursement levels lower than our current retail prices,
our margins on these sales would be reduced, and the profitability of our
business and our results of operations, financial condition or cash flows could
be adversely affected.
We are subject to governmental regulations, procedures and requirements; our
noncompliance or a significant regulatory change could adversely affect our
business, the results of our operations or our financial condition.
Our pharmacy business is subject to federal, state and local regulation.
These include local registrations of pharmacies in the states where our
pharmacies are located, applicable Medicare and Medicaid regulations, and
prohibitions against paid referrals of patients. Failure to properly adhere to
these and other applicable regulations could result in the imposition of civil
and criminal penalties and could adversely affect the continued operation of our
business. Furthermore, our pharmacies could be affected by federal and state
reform programs, such as healthcare reform initiatives which could, in turn,
negatively affect our business. The passing of these initiatives or any new
federal or state programs could adversely affect our results of operations,
financial condition or cash flows.
14
Certain risks are inherent in the provision of pharmacy services; our insurance
may not be adequate to cover any claims against us.
Pharmacies are exposed to risks inherent in the packaging and distribution of
pharmaceuticals and other healthcare products, such as with respect to improper
filling of prescriptions, labeling of prescriptions and adequacy of warnings.
Although we maintain professional liability and errors and omissions liability
insurance from time to time, claims often result in the payment of significant
amounts, some portions of which are not funded by insurance. We cannot assure
you that the coverage limits under our insurance programs will be adequate to
protect us against future claims, or that we will maintain this insurance on
acceptable terms in the future. Our results of operations, financial condition
or cash flows may be adversely affected if in the future our insurance coverage
proves to be inadequate or unavailable, there is an increase in liability for
which we self insure, or we suffer harm to our reputation as a result of an
error or omission.
We will not be able to compete effectively if we are unable to attract, hire and
retain qualified pharmacists.
There is a nationwide shortage of qualified pharmacists. In response, we have
implemented improved benefits and training programs in order to attract, hire
and retain qualified pharmacists. However, we may not be able to attract, hire
and retain enough qualified pharmacists. This could adversely affect our
operations.
Risks Related to the Notes
Since the notes are effectively subordinated to all of our secured debt and the
liabilities of our subsidiaries, we may not have sufficient assets to pay
amounts owed on the notes if a default occurs.
The notes are generally unsecured senior obligations that rank equal in right
of payment with all of our existing and future unsecured and unsubordinated
debt. The notes are effectively subordinated to all of our secured debt to the
extent of the value of the assets securing that debt. Also, the notes are
structurally subordinated to all existing and future obligations of our
subsidiaries.
We are a holding company with no direct operations. Our principal assets are
the equity interests we hold in our operating subsidiaries. As a result, we are
dependent upon dividends and other payments from our subsidiaries to generate
the funds necessary to meet our financial obligations, including the payment of
principal and interest on our outstanding debt. Our subsidiaries are legally
distinct from us and have no obligation to pay amounts due on the notes or to
make funds available to us for such payment. As of March 2, 2002, we had
approximately $1.7 billion of indebtedness (excluding lease financing
obligations) to which the notes would have been structurally subordinated in
right of payment. In addition, the notes are structurally subordinated to a
substantial amount of other liabilities, including trade payables, that do not
constitute indebtedness.
Because the obligations under our new credit facility, our 10.5% senior notes
due 2002, the 12.5% secured notes due 2006 and our new settlement senior secured
notes due 2006 are guaranteed on a secured basis by substantially all of our
subsidiaries, failure to comply with those obligations or our inability to pay
that indebtedness when due would entitle those creditors immediately to
foreclose on certain of our assets in the case of our new credit facility, and
substantially all of the assets of our subsidiaries, which serve as collateral.
In this event, those secured lenders would be entitled to be repaid in full from
the proceeds of the liquidation of those assets before those assets would be
available for distribution to other creditors, and, lastly to the holders of our
and our subsidiaries' capital stock, including holders of the common stock of
Rite Aid Corporation.
Holders of the notes will only be creditors of Rite Aid Corporation and not
of our subsidiaries. The ability of our creditors, including you, to participate
in any distribution of assets of any of our subsidiaries upon liquidation or
bankruptcy will be subject to the prior claims of that subsidiary's creditors,
including trade creditors, and any prior or equal claim of any equity holder of
that subsidiary. As a result, you may receive less, proportionately, than our
secured creditors and the creditors of our subsidiaries.
15
We may be unable to purchase the notes upon a change of control.
Upon a change of control event, we would be required to offer to purchase the
notes for cash at a price equal to 100% of their aggregate principal amount,
plus accrued and unpaid interest, if any. The terms of the notes may not protect
you if we undergo a highly leveraged transaction, reorganization, restructuring,
merger or similar transaction that may adversely affect you unless the
transaction is included within the definition of a change of control.
Our senior credit facility provides that the occurrence of certain events
that would constitute a change in control for the purposes of the notes
constitutes a default under such facility. Much of our other debt also requires
us to repurchase such debt upon an event that would constitute a change in
control for the purposes of the notes. Other future debt may contain
prohibitions of events that would constitute a change in control or that would
require such debt to be repurchased upon a change in control. Moreover, the
exercise by holders of notes of their right to require us to repurchase their
notes could cause a default under our existing or future debt, even if the
change in control itself does not result in a default under existing or future
debt, due to the financial effect of such repurchase on us. Finally, our ability
to pay cash to holders of notes upon a repurchase may be limited by our
financial resources at the time of such repurchase. Therefore, we cannot assure
you that sufficient funds will be available when necessary to make any required
repurchases. Our failure to purchase notes in connection with a change in
control would result in a default under the indenture governing the notes. Such
a default would, in turn, constitute a default under much of our existing debt,
and may constitute a default under future debt as well.
You may find it difficult to resell your notes.
Since their issuance, there has not been a significant market for the notes.
Although the initial purchasers advised us at the time we issued the notes that
they intended to make a market in the notes, they are not obligated to do so and
may discontinue such market making at any time without notice. In addition, such
market making activity will be subject to the limits imposed by the Securities
Act and the Exchange Act. Accordingly, there can be no assurance that any market
for the notes will develop or, if one does develop, that it will be maintained.
If an active market for the notes fails to develop or be sustained, the trading
price of the notes could be materially adversely affected. We do not intend to
apply for listing of the notes on any securities exchange.
Risks Related to Our Common Stock
You may not be able to sell the common stock issued upon conversion of the notes
when you want to and, if you do, you may not be able to receive the price that
you want.
Although our common stock has been actively traded on the New York Stock
Exchange and the Pacific Exchange, we do not know if an active trading market
for the common stock will continue or, if it does, at what prices the common
stock may trade. Since the beginning of fiscal 2000, the reported closing
prices for our common stock have ranged from a high of $41.375 to a low of
$1.75. In addition, the stock markets in general, including the New York Stock
Exchange, recently experienced extreme price and trading volume fluctuations.
These fluctuations have resulted in volatility in the market prices of
securities that has often been unrelated or disproportionate to changes in
operating performance. These broad market fluctuations may adversely affect the
market prices of the notes and our common stock. Further, the shares of our
common stock issued upon conversion of the notes offered by this prospectus, as
well as the other expected and possible issuances described below, will
significantly increase the number of shares of our common stock outstanding,
and could result in a decline in the market price of our common stock.
Therefore, you may not be able to sell the common stock when you want and, if
you do, you may not receive the price you want.
16
Various planned issuances of stock will be, and our continuing debt
restructuring efforts may be, dilutive to shares issued upon conversion of the
notes.
At March 2, 2002, 515.1 million shares of our common stock were
outstanding and an additional 174.7 million shares of our common stock were
issuable related to outstanding stock options, convertible notes, preferred
stock and warrants. We will also issue additional shares of common
stock pursuant to outstanding options granted pursuant to our various stock
option plans. In addition, we may undertake additional transactions to simplify
and restructure our capital structure, which may include, as part of these
efforts, additional issuances of equity securities in exchange for our
indebtedness. The issuance of additional shares of common stock may be dilutive
to the holders of our common stock, including shares of common stock issued
upon conversion of the notes. We cannot predict the extent to which the
dilution will negatively affect the trading price of our common stock or the
liquidity of our common stock.
17
USE OF PROCEEDS
We will not receive any of the proceeds of sales by the selling security
holders.
RATIO OF EARNINGS TO FIXED CHARGES
We have calculated the ratio of earnings to fixed charges in the following
table by dividing earnings by fixed charges. For this purpose, earnings include
pre-tax income from continuing operations plus fixed charges. Fixed charges
include interest, whether expensed or capitalized, amortization of debt expense,
preferred stock dividend requirement and that portion of rental expense which is
representative of the interest factor in those rentals.
Year Ended
---------------- --------------------------------------------------------------------------
March 2, 2002 March 3, 2001 February 27, 2000 February 27, 1999 February 28, 1998
(52 weeks) (53 weeks) (52 weeks) (52 weeks) (52 weeks)
---------------- ------------- ----------------- ----------------- -----------------
(Dollars in thousands)
Fixed Charges:
Interest Expense ................ $ 396,064 $ 649,926 $ 542,028 $ 274,826 $ 209,152
Interest Portion of Net Rental
Expense (1).................... 182,260 159,066 146,852 139,104 121,694
---------- ----------- ----------- --------- ---------
Fixed Charges Before Capitalized
Interest and Preferred Stock
Dividend Requirements.......... 578,324 808,992 688,880 413,930 330,846
Preferred Stock Dividend
Requirement (2)................ 42,354 42,445 15,554 965 --
Capitalized Interest ............ 806 1,836 5,292 7,069 4,102
---------- ----------- ----------- --------- ---------
Total Fixed Charges.............. $ 621,484 $ 853,273 $ 709,726 $ 421,964 $ 334,948
---------- ----------- ----------- --------- ---------
Earnings:
Loss From Continuing Operations
Before Income Taxes,
Extraordinary Item and
Cumulative Effect of Accounting
Change......................... $ (772,837) $(1,282,807) $(1,123,296) $(665,040) $(173,090)
Share of Loss From Equity Method
Investees...................... 12,092 36,675 15,181 448 1,886
Fixed Charges Before Capitalized
Interest....................... 620,678 851,437 704,434 414,895 330,846
---------- ----------- ----------- --------- ---------
Total Adjusted Earnings (Loss)... (140,067) (394,695) (403,681) (249,697) 159,642
---------- ----------- ----------- --------- ---------
Earnings to Fixed Charges,
Deficiency..................... $(761,551) $(1,247,968) $(1,113,407) $(671,661) $(175,306)
========== =========== =========== ========= =========
---------------
(1) The Interest Portion of Net Rental Expense is estimated to be equal to one-
third of the minimum rental expense for the period.
(2) The Preferred Stock Dividend Requirement is computed as the pre-tax earnings
that would be required to cover preferred stock dividends.
18
SELLING SECURITY HOLDERS
The notes were originally issued by us and sold by the initial purchasers in
transactions exempt from the registration requirements of the Securities Act
pursuant to Rule 144A under the Securities Act or in offshore transactions under
Regulation S under the Securities Act. The selling security holders may from
time to time offer and sell pursuant to this prospectus any or all of the notes
listed below and the shares of common stock issued upon conversion of such
notes. When we refer to the "selling security holders" in this prospectus, we
mean those persons listed in the table below, as well as the pledgees, donees,
assignees, transferees, successors and others who later hold any of the selling
security holders' interests.
The table below sets forth the name of each selling security holder, the
principal amount at maturity of notes that each selling security holder may
offer pursuant to this prospectus and the number of shares of common stock into
which such notes are convertible. Unless set forth below, to our knowledge, none
of the selling security holders has, or within the past three years has had, any
material relationship with us or any of our predecessors or affiliates or
beneficially owns in excess of 1% of the outstanding common stock.
The principal amounts of the notes provided in the table below is based on
information provided to us by each of the selling security holders as of
May 14, 2002, and the percentages are based on $250,000,000 principal
amount at maturity of notes outstanding. The number of shares of common stock
that may be sold is calculated based on the current conversion price of $6.50
per share.
Since the date on which each selling security holder provided this
information, each selling security holder identified below may have sold,
transferred or otherwise disposed of all or a portion of its notes in a
transaction exempt from the registration requirements of the Securities Act.
Information concerning the selling security holders may change from time to time
and any changed information will be set forth in supplements to this prospectus
to the extent required. In addition, the conversion ratio, and therefore the
number of shares of our common stock issuable upon conversion of the notes, is
subject to adjustment. Accordingly, the number of shares of common stock
issuable upon conversion of the notes may increase or decrease.
19
The selling security holders may from time to time offer and sell any or all
of the securities under this prospectus. Because the selling security holders
are not obligated to sell the notes or the shares of common stock issuable upon
conversion of the notes, we cannot estimate the amount of the notes or how many
shares of common stock that the selling security holders will hold upon
consummation of any such sales.
Aggregate principal Number of shares of
amount at maturity common stock that Percentage of shares
Name of notes that may be Percentage of notes may be sold by this of common stock
---- sold by this prospectus outstanding prospectus(1) outstanding(2)
----------------------- ------------------- ------------------- --------------------
Argent Classic Convertible
Arbitrage Fund L.P................ $ 2,500,000 1.0 384,615 *
Argent Classic Convertible
Arbitrage Fund (Bermuda) Ltd...... 3,500,000 1.4 538,462 *
Argent LowLev Convertible
Arbitrage Fund Ltd................ 2,000,000 * 307,692 *
Aristeia Trading, LLC .............. 3,080,000 1.2 473,846 *
Aristeia International Limited ..... 10,920,000 4.4 1,680,000 *
Bank Austria Cayman Islands LTD .... 4,455,000 1.8 685,385 *
BNP Paribas Equity Strategies SNC 500,000 * 76,293 *
BP Amoco PLC, Master Trust ......... 211,000 * 32,462 *
Canyon Capital Arbitrage Master
Fund, Ltd......................... 6,000,000 2.4 923,077 *
Canyon MAC 18 (RMF), Ltd. .......... 2,500,000 1.0 384,615 *
Canyon Value Realization Fund
(Cayman), Ltd..................... 12,000,000 4.8 1,846,154 *
Canyon Value Realization Fund, L.P. 7,000,000 2.8 1,076,923 *
Coastal Convertibles Ltd ........... 1,000,000 * 153,846 *
Deutsche Banc Alex. Brown Inc. ..... 5,500,000 2.2 846,154 *
DLB High Yield Fund ................ 100,000 * 15,385 *
Dresdner Kleinwort Wasserstein
Grantchester Inc. ................ 500,000 * 76,293 *
Fidelity Advisor Series II:
Fidelity Advisor High Yield Fund .. 10,250,000 4.1 1,576,923 *
Fidelity Financial Trust:
Fidelity Convertible Securities
Fund.............................. 1,255,000 * 193,077 *
First Union National Bank .......... 21,225,000 8.5 3,265,385 *
First Union Securities Inc. ........ 15,000,000 6.0 2,307,692 *
Global Bermuda Limited Partnership . 400,000 * 61,538 *
Goldman Sachs & Company ............ 1,975,000 * 303,846 *
Highbridge International LLC ....... 8,500,000 3.4 1,307,692 *
KBC Financial Products USA Inc. .... 1,240,000 * 190,769 *
Lakeshore International, Ltd. ...... 1,600,000 * 246,154 *
Lincoln National Global Asset
Allocation Fund, Inc. ........... 125,000 * 19,231 *
Massachusetts Mutual Life Insurance
Company........................... 675,000 * 103,846 *
MassMutual Asia Limited ............ 25,000 * 3,846 *
MassMutual Corporate Investors ..... 200,000 * 30,769 *
Merced Partners Limited Partnership 1,500,000 * 230,769 *
Onyx Fund Holdings, LDC ............ 2,500,000 1.0 384,615 *
Pioneer High Yield Fund ............ 1,000,000 * 153,846 *
Putnam Asset Allocation Funds-
Balanced Portfolio ............... 1,050,000 * 161,538 *
Putnam Asset Allocation Funds-
Conservative Portfolio ........... 830,000 * 127,692 *
Putnam Convertible Income-Growth
Trust ............................ 7,210,000 2.9 1,109,231 *
Putnam Convertible Opportunities
and Income Trust ................. 264,000 * 40,615 *
Putnam Variable Trust-Putnam VT
Global Asset Allocation Fund ..... 255,000 * 39,231 *
Ramius Capital Group ............... 590,000 * 90,769 *
RCG Halifax Master Fund, LTD........ 1,340,000 * 206,154 *
(Continued on following page)
20
(Continued from previous page)
Aggregate principal Number of shares of
amount at maturity common stock that Percentage of shares
Name of notes that may be Percentage of notes may be sold by this of common stock
---- sold by this prospectus outstanding prospectus(1) outstanding(2)
----------------------- ------------------- ------------------- --------------------
RCG Latitude Master Fund, LTD ...... 2,445,000 1.0 376,154 *
RCG Multi Strategy LP .............. 2,260,000 * 347,692 *
St. Albans Partners Ltd. ........... 3,000,000 1.2 461,538 *
Tamarack International, Ltd. ....... 1,500,000 * 230,769 *
The Estate of James Campbell ....... 320,000 * 49,231 *
The James Campbell Corporation ..... 423,000 * 65,077 *
TQA Master Fund, Ltd. .............. 2,000,000 * 307,692 *
TQA Master Plus Fund, Ltd. ......... 2,000,000 * 307,692 *
Zazove Hedged Convertible Fund LP... 1,000,000 * 153,846 *
Zurich Institutional Benchmarks .... 546,000 * 84,000 *
All other holders of notes or
future transferees, pledgees,
donees, assignees or successors of
any such holders (3) (4).......... $ 93,731,000 37.5% 14,420,154 2.7%
------------ ----- ---------- ---
Total .............................. $250,000,000 100.0% 38,461,539(5) 7.0%(6)
============ ===== ========== ===
---------------
* Less than one percent
(1) Assumes conversion of all of the holder's notes at a conversion rate of
153.846 shares of common stock per $1,000 principal amount at maturity of
the notes. This conversion rate is subject to adjustment, however, as
described under "Description of Notes--Conversion Rights." As a result, the
number of shares of common stock issuable upon conversion of the notes may
increase or decrease in the future.
(2) Calculated based on Rule 13d-3(d)(1)(i) of the Exchange Act, using
515,113,894 shares of common stock outstanding as of May 1, 2002. In
calculating this amount for each holder, we treated as outstanding the
number of shares of common stock issuable upon conversion of all that
holder's notes, but we did not assume conversion of any other holder's
notes.
(3) Information about other selling shareholders will be set forth in prospectus
supplements, if required.
(4) Assumes that any other holders of the notes or any future pledgees, donees,
assignees, transferees or successors of or from such other holders of the
notes do not beneficially own any shares of common stock other than the
common stock issuable upon conversion of the notes at the initial conversion
rate described in footnote 1 above.
(5) Represents the number of shares of common stock into which $250,000,000 of
notes would be convertible at the initial conversion rate described in
footnote 1 above.
(6) Represents the amount which the selling security holders may sell under
this prospectus divided by the sum of 515,113,894 shares of common stock
outstanding as of May 1, 2002 and the number of shares of common stock
into which $250,000,000 of notes would be convertible at the initial
conversion rate described in footnote 1 above.
21
DESCRIPTION OF NOTES
In this description, the words "Company," "we," "us" and "our" refer only to
Rite Aid Corporation and not to any of our subsidiaries.
We issued the notes under an indenture, dated as of November 19, 2001 (the
"Indenture"), between us and BNY Midwest Trust Company, as trustee.
Wherever particular defined terms of the Indenture (including the notes and
the various forms thereof) are referred to, such defined terms are incorporated
herein by reference (the notes and various terms relating to the notes being
referred to in the Indenture as "Securities").
We urge you to read the Indenture because it, and not this description,
defines your rights as a holder of these notes. A copy of the Indenture is
available upon request to us at the address indicated under "Where You Can Find
More Information."
General
The notes are our unsecured unsubordinated obligations, are limited to
$250,000,000 aggregate principal amount at maturity and will mature on December
1, 2006. Payment in full of the principal amount of the notes is due on December
1, 2006. The notes bear interest at the rate of 4.75% per annum from November
19, 2001, payable semiannually on June 1 and December 1 of each year, commencing
on June 1, 2002.
The notes are convertible into shares of our common stock, par value $1.00
per share (the "Common Stock"), initially at the conversion price stated on the
cover page of this prospectus, subject to adjustment upon the occurrence of
certain events described under "--Conversion Rights," at any time prior to the
close of business on the maturity date, unless previously redeemed or
repurchased.
The notes are redeemable under the circumstances and at the redemption prices
set forth below under "--Optional Redemption," plus accrued interest and
liquidated damages, if any, to the redemption date. The notes are also subject
to our repurchase at the option of the holders, as described below under
"--Repurchase at Option of Holders Upon a Change in Control."
Ranking
The notes are:
o our unsubordinated, unsecured obligations; and
o equal in ranking ("pari passu") with all of our existing and future
unsubordinated, unsecured debt.
We and our subsidiaries had, as of March 2, 2002, approximately $4.1 billion
of outstanding indebtedness, including lease financing obligations. We also had
additional borrowing capacity under our new revolving credit facility of $438.7
million as of that date, net of outstanding letters of credit of $61.3 million.
The notes are effectively subordinated to all of our secured debt to the
extent of the value of the assets securing that debt. Also, the notes are
structurally subordinated to all existing and future liabilities and obligations
of our subsidiaries.
We are a holding company with no direct operations. Our principal assets are
the equity interests we hold in our operating subsidiaries. As a result, we are
dependent upon dividends and other payments from our subsidiaries to generate
the funds necessary to meet our financial obligations, including the payment of
principal of and interest on our outstanding debt. Our subsidiaries are legally
distinct from us and have no obligation to pay amounts due on the notes or to
make funds available to us for such payment. As of March 2, 2002, we had
approximately $1.7 billion of indebtedness (excluding lease financing
obligations) to which the notes would have been structurally subordinated in
right of payment. In addition, the notes are structurally subordinated to a
substantial amount of other liabilities, including trade payables, that do not
constitute indebtedness.
Because the obligations under our new credit facility, our 10.5% senior notes
due 2002, the 12.5% secured notes due 2006 and our new settlement senior
secured notes due 2006 are guaranteed on a secured basis by substantially all of
our subsidiaries, failure to
22
comply with those obligations or our inability to pay that indebtedness when due
would entitle those creditors immediately to foreclose on certain of our assets
in the case of our new credit facility, and substantially all of the assets of
our subsidiaries, which serve as collateral. In this event, those secured
lenders would be entitled to be repaid in full from the proceeds of the
liquidation of those assets before those assets would be available for
distribution to other creditors, and, lastly to the holders of our and our
subsidiaries' capital stock, including holders of Common Stock.
Holders of the notes will only be creditors of Rite Aid Corporation and not
of our subsidiaries. The ability of our creditors, including you, to participate
in any distribution of assets of any of our subsidiaries upon liquidation or
bankruptcy will be subject to the prior claims of that subsidiary's creditors,
including trade creditors, and any prior or equal claim of any equity holder of
that subsidiary. As a result, you may receive less, proportionately, than our
secured creditors and the creditors of our subsidiaries.
Book-Entry; Delivery and Form; Global Note
The notes were originally sold in the United States in reliance on Rule 144A
or in offshore transactions in reliance on Regulation S and were originally
issued in the form of a single, permanent global note in definitive, fully
registered form without interest coupons. The global note was deposited with the
trustee as custodian for The Depository Trust Company ("DTC") and registered in
the name of a nominee of DTC in New York, New York for the accounts of
participants in DTC. The notes sold under this prospectus will be represented by
a new unrestricted global security.
DTC has advised us as follows: DTC is a limited purpose trust company
organized under the laws of the State of New York Uniform Commercial Code, a
"clearing corporation" within the meaning of the New York Uniform Commercial
Code and a "clearing agency" registered pursuant to the provisions of Section
17A of the Exchange Act. DTC was created to hold securities of institutions that
have accounts with DTC (which we refer to as "participants") and to facilitate
the clearance and settlement of securities transactions among its participants
in such securities through electronic book-entry changes in accounts of the
participants, thereby eliminating the need for physical movement of securities
certificates. DTC's participants include securities brokers and dealers (which
may include the initial purchasers), banks, trust companies, clearing
corporations and certain other organizations. Access to DTC's book-entry system
is also available to others such as banks, brokers, dealers and trust companies
that clear through or maintain a custodial relationship with a participant,
either directly or indirectly.
Upon the issuance of the new global note, DTC or its nominee will credit, on
its book-entry registration and transfer system, the respective principal amount
of the individual beneficial interests represented by the global note to the
accounts of participants. Ownership of beneficial interests in the global note
will be limited to participants or persons that may hold interests through
participants. Ownership of beneficial interests in the global note will be shown
on, and the transfer of those ownership interests will be effected only through,
records maintained by DTC (with respect to participants' interests) and such
participants (with respect to the owners of beneficial interests in the global
note other than participants). Investors may also hold their interests in the
global note directly through Euroclear Bank S.A./N.V., as operator of the
Euroclear System ("Euroclear") and Clearstream Banking, societe anonyme
("Clearstream"), if they are participants in such systems, or indirectly through
organizations that are participants in such systems. Euroclear and Clearstream
will hold interests in the global note on behalf of their participants through
their respective depositaries, which in turn will hold such interests in the
global note in customers' securities accounts in the depositaries' names on the
books of DTC.
So long as DTC or its nominee is the registered holder and owner of the
global note, DTC or such nominee, as the case may be, will be considered the
sole legal owner of the notes represented by the global note for all purposes
under the Indenture and the notes. Except as set forth below, owners of
beneficial interests in the global note will not be entitled to receive notes in
definitive form and will not be considered to be the owners or holders of any
notes under the global note. We understand that under existing industry
practice, in the event an owner of a beneficial interest in the global note
desires to take any actions that DTC, as the holder of the global note, is
entitled to take, DTC would authorize the participants to take such action, and
that participants would authorize beneficial owners owning through such
participants to take such action
23
or would otherwise act upon the instructions of beneficial owners owning through
them. No beneficial owner of an interest in the global note will be able to
transfer the interest except in accordance with DTC's applicable procedures, in
addition to those provided for under the Indenture and, if applicable, those of
Euroclear and Clearstream.
Payments of the principal of, premium, if any, and interest and liquidated
damages, if any, on the notes represented by the global note registered in the
name of and held by DTC or its nominee will be made to DTC or its nominee, as
the case may be, as the registered owner and holder of the global note.
We expect that DTC or its nominee, upon receipt of any payment of principal
or interest in respect of the global note, will credit participants' accounts
with payments in amounts proportionate to their respective beneficial interests
in the principal amount of the global note as shown on the records of DTC or its
nominee. We also expect that payments by participants to owners of beneficial
interests in the global note held through such participants will be governed by
standing instructions and customary practices as is now the case with securities
held for accounts of customers registered in the names of nominees for such
customers. Such payments, however, will be the responsibility of such
participants and indirect participants, and neither we, the trustee nor any
paying agent will have any responsibility or liability for any aspect of the
records relating to, or payments made on account of, beneficial ownership
interests in the global note or for maintaining, supervising or reviewing any
records relating to such beneficial ownership interests or for any other aspect
of the relationship between DTC and its participants or the relationship between
such participants and the owners of beneficial interests in the global note.
Unless and until it is exchanged in whole or in part for notes in definitive
form, the global note may not be transferred except as a whole by DTC to a
nominee of DTC or by a nominee of DTC to DTC or another nominee of DTC.
Transfers between participants in DTC will be effected in the ordinary way in
accordance with DTC rules and will be settled in same-day funds. Transfers
between participants in Euroclear and Clearstream will be effected in the
ordinary way in accordance with their respective rules and operating procedures.
The laws of some states may require that certain persons take physical delivery
of securities in definitive form. As a result, the ability to transfer
beneficial interests in a global note to such persons may be limited.
Cross-market transfers between DTC, on the one hand, and directly or
indirectly through Euroclear or Clearstream participants, on the other, will be
effected in DTC in accordance with DTC rules on behalf of Euroclear or
Clearstream, as the case may be, by its respective depositary; however, such
cross-market transactions will require delivery of instructions to Euroclear or
Clearstream, as the case may be, by the counterparty in such system in
accordance with its rules and procedures and within its established deadlines
(Brussels time). Euroclear or Clearstream, as the case may be, will, if the
transaction meets its settlement requirements, deliver instructions to its
respective depositary to take action to effect final settlement on its behalf by
delivering or receiving interests in the global note in DTC, and making or
receiving payment in accordance with normal procedures for same-day funds
settlement applicable to DTC. Euroclear participants and Clearstream
participants may not deliver instructions directly to the depositaries for
Euroclear or Clearstream.
Because of time zone differences, the securities account of a Euroclear or
Clearstream participant purchasing an interest in the global note from a DTC
participant will be credited during the securities settlement processing day
(which must be a business day for Euroclear or Clearstream, as the case may be)
immediately following the DTC settlement date, and such credit of any
transactions involving interests in the global note settled during such
processing day will be reported to the relevant Euroclear or Clearstream
participant on such day. Cash received in Euroclear or Clearstream as a result
of sales of interests in the global note by or through a Euroclear or
Clearstream participant to a DTC participant will be received with value on the
DTC settlement date, but will be available in the relevant Euroclear or
Clearstream cash account only as of the business day following settlement in
DTC.
We expect that DTC will take any action permitted to be taken by a holder of
notes (including the presentation of notes for exchange as described below) only
at the direction of one or more participants to whose account the DTC interests
in the global note is credited and only in respect of such portion of the
24
aggregate principal amount of the notes as to which such participant or
participants has or have given such direction. However, if there is an event of
default under the notes, DTC will exchange the global note for notes in
definitive form, which it will distribute to its participants.
Although we expect that DTC, Euroclear and Clearstream will agree to the
foregoing procedures in order to facilitate transfers of interests in the global
note among participants of DTC, Euroclear, and Clearstream, DTC, Euroclear and
Clearstream are under no obligation to perform or continue to perform such
procedures, and such procedures may be discontinued at any time. Neither we nor
the trustee will have any responsibility for the performance by DTC, Euroclear
or Clearstream or their participants or indirect participants of their
respective obligations under the rules and procedures governing their
operations.
Certificated Notes
If DTC is unwilling or unable to continue as depository for a global note, is
closed for business for 14 continuous days, ceases to be a "Clearing Agency"
registered under the Exchange Act or announces an intention permanently to cease
business or does in fact do so, or an Event of Default has occurred and is
continuing with respect to a global note, we will issue certificates for the
notes in definitive, fully registered, non-global form without interest coupons
in exchange for the global notes, as the case may be.
The holder of a note in non-global form may transfer such note, subject to
compliance with the provisions of any legend, by surrendering it at the office
or agency we maintain for such purpose in the Borough of Manhattan, the City of
New York, which initially will be the office of the trustee. Upon the transfer,
exchange or replacement of notes bearing the legend, or upon specific request
for removal of the legend on a note, we will deliver only notes that bear such
legend, or will refuse to remove such legend, as the case may be, unless there
is delivered to us such satisfactory evidence, which may include an opinion of
counsel, as we may reasonably require that neither the legend nor the
restrictions on transfer set forth therein are required to ensure compliance
with the provisions of the Securities Act. Before any note in non-global form
may be transferred to a person who takes delivery in the form of an interest in
any global note, the transferor will be required to provide the trustee with a
global note certificate, as the case may be.
Notwithstanding any statement herein, we and the trustee reserve the right to
impose such transfer, certification, exchange or other requirements, and to
require such restrictive legends on certificates evidencing notes, as they may
determine are necessary to ensure compliance with the securities laws of the
United States and the States therein and any other applicable laws, to ensure
that the Shelf Registration Statement or amendment covering the notes and the
Common Stock is declared effective by the SEC or as DTC may require.
Conversion Rights
The holder of any note has the right, at the holder's option, to convert any
portion of the principal amount of a registered note that is an integral
multiple of $1,000 into shares of Common Stock at any time prior to the close of
business on the maturity date, unless previously redeemed or repurchased, at a
conversion rate of 153.846 shares per $1,000 principal amount of notes
(equivalent to a conversion price of $6.50 per share) (subject to adjustment as
described below). The right to convert a note called for redemption or delivered
for repurchase will terminate at the close of business on the redemption date or
repurchase date for the note.
The right of conversion attaching to any note may be exercised by the holder
by delivering the note at the specified office of the Conversion Agent,
accompanied by a duly signed and completed notice of conversion, a copy of which
may be obtained from the Conversion Agent. Beneficial owners of interest in a
global note may exercise their rights of conversion by delivering to DTC the
appropriate instruction forms for conversion pursuant to DTC's conversion
program. The conversion date will be the date on which the note and the duly
signed and completed notice of conversion are delivered, unless otherwise
provided by the notice. As promptly as practicable on or after the conversion
date, we will issue and deliver to the trustee a certificate or certificates for
the number of full shares of Common Stock issuable upon conversion, together
with payment in lieu of any fraction of a share or, at our option, rounded up to
the next whole number of shares; the certificate, and payment, if any, will be
sent by the trustee to the Conversion Agent for delivery to
25
the holder. Any note surrendered for conversion during the period from the close
of business on any Regular Record Date to the opening of business on the next
succeeding Interest Payment Date (except notes called for redemption on a
Redemption Date or to be repurchased on a Repurchase Date and as a result, the
right to convert the notes with respect to which redemption or repurchase rights
have been exercised would terminate during such period) must be accompanied by
payment in New York Clearing House Funds or other funds acceptable to us of an
amount equal to the interest payable on that Interest Payment Date on the
principal amount of those notes being surrendered for conversion. In the case of
any note which has been converted after any Regular Record Date but before the
next Interest Payment Date, interest which has a Stated Maturity on that
Interest Payment Date will be payable on that Interest Payment Date
notwithstanding the conversion, and the interest will be paid to the holder of
that note on that Regular Record Date. As a result of the foregoing provisions,
holders that surrender notes for conversion on a date that is not an Interest
Payment Date will not receive any interest for the period from the Interest
Payment Date next preceding the date of conversion to the date of conversion or
for any later period, even if the notes are surrendered after a notice of
redemption (except for the payment of interest on notes called for redemption on
a Redemption Date or to be repurchased on a Repurchase Date for which the right
to convert those notes would terminate during the period between a Regular
Record Date and the Interest Payment Date to which it relates).
No other payment or adjustment for interest, or for any dividends with
respect to Common Stock, will be made upon conversion. Holders of Common Stock
issued upon conversion will not be entitled to receive any dividends payable to
holders of Common Stock as of any record time before the close of business on
the conversion date. No fractional shares will be issued upon conversion but, in
lieu thereof, we will calculate an appropriate amount to be paid in cash based
on the market price of Common Stock at the close of business on the day of
conversion. That market price will be calculated by us and will be deemed to be
the average of the daily Closing Prices per share for the five consecutive
Trading Days selected by the Company commencing not more than 10 Trading Days
before, and ending not later than, the earlier of the day in question and the
day before the "ex" date with respect to an issuance or distribution requiring
such computation. The term "ex" date, when used with respect to any issuance or
distribution, means the first date on which the Common Stock trades without the
right to receive an issuance or distribution. "Closing Price Per Share" means,
for any day, the last reported sales price per share on the NYSE. A "Trading
Day" is any day on which the NYSE is open for business.
A holder delivering a note for conversion will not be required to pay any
taxes or duties in respect of the issue or delivery of Common Stock on
conversion but will be required to pay any tax or duty which may be payable in
respect of any transfer involved in the issue or delivery of the Common Stock in
a name other than that of the holder of the note. Certificates representing
shares of Common Stock will not be issued or delivered unless the person
requesting the issue has paid to the Company the amount of any tax or duty or
has established to our satisfaction that the tax or duty has been paid.
The conversion rate is subject to adjustment in certain events, including:
(a) dividends (and other distributions) payable in Common Stock on
shares of our capital stock,
(b) the issuance to all holders of Common Stock of rights, options or
warrants entitling them to subscribe for or purchase Common Stock at
less than the then-current market price (determined as provided in the
Indenture) of Common Stock,
(c) subdivisions, combinations and reclassifications of Common Stock,
(d) distributions to all holders of Common Stock of evidences of our
indebtedness, shares of capital stock, cash or assets (including
securities, but excluding those dividends, rights, options, warrants
and distributions referred to above, dividends and distributions paid
exclusively in cash and distributions upon mergers or consolidations
to which the next succeeding paragraph applies),
(e) distributions consisting exclusively of cash (excluding any cash
portion of distributions referred to in (d) above, or cash distributed
upon a merger or consolidation to which the next succeeding paragraph
applies) to all holders of Common Stock in an aggregate amount that,
combined together with (i) other such all-cash distributions made
within the preceding 12 months in respect of which no adjustment has
been made and (ii) any cash and the fair market value of other
consideration
26
payable in respect of any tender offer by the Company or any of its
subsidiaries for Common Stock concluded within the preceding 12 months
in respect of which no adjustment has been made, exceeds 12.5% of our
market capitalization (being the product of the then- current market
price of the Common Stock and the number of shares of Common Stock
then outstanding) on the record date for such distribution, and
(f) the successful completion of a tender offer made by us or any of our
subsidiaries for Common Stock which involves an aggregate
consideration that, together with (i) any cash and other consideration
payable in a tender offer by us or any of our subsidiaries for Common
Stock expiring within the 12 months preceding the expiration of such
tender offer in respect of which no adjustment has been made and (ii)
the aggregate amount of any such all-cash distributions referred to in
(e) above to all holders of Common Stock within the 12 months
preceding the expiration of such tender offer in respect of which no
adjustments have been made, exceeds 12.5% of our market capitalization
on the expiration of such tender offer.
We reserve the right to make increases in the conversion rate in addition to
those required in the foregoing provisions as it considers to be advisable in
order that any event treated for federal income tax purposes as a dividend or
distribution of stock or issuance of rights or warrants to purchase or subscribe
for stock will not be taxable to the recipients. No adjustment of the conversion
rate will be required to be made until the cumulative adjustments amount to 1.0%
or more of the conversion rate. We will compute any adjustments to the
conversion price pursuant to this paragraph and will give notice to the holders
of the notes of any adjustments.
In case of our consolidation or merger with or into another Person or any
merger of another Person into us (other than a merger which does not result in
any reclassification, conversion, exchange or cancellation of the Common Stock),
or in case of any sale or transfer of all or substantially all of our assets,
each note then outstanding will, without the consent of the holder of any note
or coupon, become convertible only into the kind and amount of securities, cash
and other property, if any, receivable upon such consolidation, merger, sale or
transfer by a holder of the number of shares of Common Stock into which such
note was convertible immediately prior thereto (assuming such holder of Common
Stock failed to exercise any rights of election and that such note was then
convertible).
If at any time we make a distribution of property to our security holders
which would be taxable to such security holders as a dividend for federal income
tax purposes (e.g., distribution of evidences of indebtedness or our assets, but
generally not stock dividends on Common Stock or rights to subscribe for Common
Stock) and, pursuant to the antidilution provisions of the Indenture, the number
of shares into which notes are convertible is increased, such increase may be
deemed for federal income tax purposes to be the payment of a taxable dividend
to holders of notes. See "Certain United States Federal Income Tax
Consequences."
Optional Redemption
We may not redeem the notes in whole or in part at any time prior to December
5, 2004. At any time on or after December 5, 2004, we may redeem some or all of
the notes on at least 20 but not more than 60 days' notice (which notice must be
given no later than the close of business on the tenth business day immediately
following the conclusion of the 30 Trading Day period referred to below) if for
20 Trading Days within any period equals or of 30 consecutive Trading Days,
including the last day of such period, the Current Market Price of the Common
Stock equals or exceeds 125% of the then prevailing conversion price, at the
following redemption prices (expressed in percentages of the principal amount):
During the Twelve Months Commencing Redemption Price
----------------------------------- ----------------
December 5, 2004 101.90%
December 5, 2005 100.95%
In addition, we will pay interest and liquidated damages, if any, on the
notes being redeemed, including those notes which are converted into Common
Stock after the date the notice of the redemption is mailed and prior to the
Redemption Date. This payment will include interest and liquidated damages, if
any, accrued and
27
unpaid to, but excluding, the Redemption Date. If the Redemption Date is an
interest payment date, we will pay the interest and liquidated damages, if any,
to the holder of record on the corresponding record date, which may or may not
be the same person to whom we will pay the redemption price.
If we do not redeem all of the notes, the trustee will select the notes to be
redeemed in principal amounts of $1,000 or whole multiples of $1,000 by lot or
on a pro rata basis. If any notes are to be redeemed in part only, we will issue
a new note or notes in principal amount equal to the unredeemed principal
portion thereof. If a portion of your notes is selected for partial redemption
and you convert a portion of your notes, the converted portion will be deemed to
be taken from the portion selected for redemption.
The term "conversion price" means $1,000 divided by the conversion rate. The
term "Current Market Price" of Common Stock for any day means the last reported
per share sale price, regular way on such day, or, if no sale takes place on
such day, the average of the reported closing per share bid and asked prices on
such day, regular way, in either case as reported on the New York Stock Exchange
or, if the Common Stock is not listed or admitted to trading on such exchange,
on the principal national securities exchange or quotation system on which the
Common Stock may be listed or admitted to trading or quoted, or, if not listed
or admitted to trading or quoted on any national securities exchange or
quotation system, the average of the closing per share bid and asked prices of
the Common Stock on the over-the-counter market on the day in question as
reported by the National Quotation Bureau Incorporated, or similar generally
accepted reporting service, or, if not so available in such manner, as furnished
by any New York Stock Exchange member firm selected from time to time by our
Board of Directors for that purpose, or, if not so available in such manner, as
otherwise determined in good faith by our Board of Directors.
Repurchase at Option of Holders Upon a Change in Control
If a Change in Control (as defined) occurs, each holder of notes shall have
the right, at the holder's option, to require us to repurchase all of the
holder's notes, or any portion of the principal amount thereof that is equal to
$1,000 or an integral multiple of $1,000 in excess thereof, on the date (the
"Repurchase Date") that is 45 days after the date of the Company Notice (as
defined), at a price equal to 100% of the principal amount of the notes to be
repurchased (the "Repurchase Price"), together with interest accrued and
liquidated damages, if any, to the Repurchase Date.
Within 30 days after the occurrence of a Change in Control, we are obligated
to give to all holders of the notes notice, as provided in the Indenture (the
"Company Notice"), of the occurrence of a Change in Control and of the
repurchase right arising therefrom. The Company Notice shall be sufficiently
given to holders of notes if in writing and mailed, first class postage prepaid,
to each holder of a note affected by the event, at the address of such holder.
We must also deliver a copy of the Company Notice to the trustee. To exercise
the repurchase right, a holder of notes must deliver on or before the 30th day
after the date of the Company Notice irrevocable written notice to the trustee
of the holder's exercise of such right, together with the notes with respect to
which the right is being exercised.
A Change in Control occurs in the following situations:
(i) any person, including any syndicate or group deemed to be a "person"
under Section 13(d)(3) of the Exchange Act, acquires beneficial
ownership, directly or indirectly, through a purchase, merger or other
acquisition transaction or series of transactions, of shares of our
capital stock entitling the person to exercise 50% or more of the
total voting power of all shares of our capital stock that are
entitled to vote generally in elections of directors;
(ii) we merge or consolidate with or into any other person, any other
person merges into us, or we convey, sell, transfer or lease all or
substantially all of our assets to another person, other than any such
transaction:
(a) that does not result in (1) any reclassification, conversion,
exchange or cancellation of outstanding shares of our capital
stock, and (2) pursuant to which the holders of 50% or more of
the total voting power of all shares of our capital stock
entitled to vote generally in elections of directors immediately
prior to such transaction have the entitlement to exercise,
directly or indirectly, 50% or more of the total voting power of
all shares of capital stock entitled to vote
28
generally in the election of directors of the continuing or
surviving corporation immediately after such transaction, or
(b) which is effected solely to change our jurisdiction of
incorporation and results in a reclassification, conversion or
exchange of outstanding shares of the Common Stock into solely
shares of common stock; or
(iii) our Common Stock (a) ceases to be listed, traded or quoted (or
admitted for such a purpose) on a national securities exchange, the
Nasdaq National Market, any other quotation system or over-the-
counter market or (b) ceases to be registered under the Exchange Act;
provided, however, a Change in Control shall not be deemed to have occurred if
either (a) the closing price per share of the Common Stock for any five Trading
Days within the period of 10 consecutive Trading Days ending immediately after
the later of the Change in Control or the public announcement of the Change in
Control (in the case of a Change in Control under clause (i) above) or ending
immediately before the Change in Control (in the case of a Change in Control
under clause (ii) above) shall equal or exceed 105% of the conversion price of
the notes in effect on each such Trading Day, or (b) all of the consideration
(excluding cash payments for fractional shares) in the transaction or
transactions constituting the Change in Control consists of common stock traded
on a national securities exchange or quoted on the Nasdaq National Market and as
a result of such transaction or transactions the notes become convertible solely
into such common stock.
Our failure to repurchase the notes when required would result in an Event of
Default with respect to the notes. See "--Events of Default."
Rule 13e-4 under the Exchange Act requires the dissemination of certain
information to security holders in the event of an issuer tender offer and may
apply in the event that the repurchase option becomes available to holders of
the notes. We will comply with this rule to the extent applicable at that time.
The Change in Control repurchase feature is a result of negotiations between
us and the initial purchasers. Management has no present intention to engage in
a transaction involving a Change in Control, although it is possible that we
would decide to do so in the future. Subject to the covenants described below,
we could, in the future, enter into transactions, including acquisitions,
refinancings or other recapitalizations, that would not constitute a Change in
Control under the Indenture, but that could increase the amount of debt
outstanding at such time or otherwise affect our capital structure or credit
ratings.
Our senior credit facility provides that the occurrence of certain events
that would constitute a Change in Control constitutes a default under such
facility. Much of our other debt also requires us to repurchase such debt upon
an event that would constitute a Change in Control for the purposes of the
notes. Other future debt of ours may contain prohibitions of events that would
constitute a Change in Control or that would require such debt to be repurchased
upon a Change in Control. Moreover, the exercise by holders of notes of their
right to require us to repurchase their notes could cause a default under our
existing or future debt, even if the change in control itself does not result in
a default under our existing or future debt, due to the financial effect of such
repurchase on us. Finally, our ability to pay cash to holders of notes upon a
repurchase may be limited by our financial resources at the time of such
repurchase. Therefore, we cannot assure you that sufficient funds will be
available when necessary to make any required repurchases. Our failure to
purchase notes in connection with a Change in Control would result in a default
under the Indenture. Such a default would, in turn, constitute a default under
much of our existing debt, and may constitute a default under future debt as
well. Our obligation to make an offer to repurchase the notes as a result of a
Change in Control may be waived or modified at any time prior to the occurrence
of such Change in Control with the written consent of the holders of a majority
in aggregate principal amount of the outstanding notes.
The foregoing provisions would not necessarily afford holders of the notes
protection in the event of highly leveraged or other transactions involving us
that may adversely affect holders.
29
Mergers and Sales of Assets by the Company
We may not consolidate with or merge into any other Person or, directly or
indirectly, convey, transfer, sell, lease or otherwise dispose of all or
substantially all of our properties and assets to any Person (other than a
wholly owned subsidiary), and we may not permit any Person (other than a wholly
owned subsidiary) to consolidate with or merge into us or convey, transfer,
sell, lease or otherwise dispose of all or substantially all of its properties
and assets to us, unless:
(a) the Person formed by such consolidation or into which we are merged or
the Person to which our properties and assets are so transferred or
leased is a corporation, limited liability company, partnership or
trust organized and existing under the laws of the United States, any
State thereof or the District of Columbia and has expressly assumed
the due and punctual payment of the principal of, premium, if any, and
interest on the notes and coupons and the performance of our other
covenants under the Indenture,
(b) immediately after giving effect to such transaction and treating any
indebtedness which becomes an obligation of ours or a Subsidiary as a
result of such transaction as having been incurred by us or Subsidiary
at the time of such transaction, no Event of Default, and no event
which, after notice or lapse of time or both, would become an Event of
Default, will have occurred and be continuing, and
(c) We have provided to the trustee an Officers' Certificate and Opinion
of Counsel as provided in the Indenture.
Events of Default
The following are Events of Default under the Indenture:
(a) failure to pay any interest (including liquidated damages) on any note
or coupon when due, which failure continues for 30 days;
(b) failure to pay the principal or Redemption Price or Repurchase Price
of any note when due;
(c) default in our obligation to provide notice of a Change in Control;
(d) our failure to perform any other covenant or warranty in the
Indenture, which failure continues for 60 days after written notice to
the Company by the trustee as provided in the Indenture;
(e) default under any bond, debenture, note or other evidence of
Indebtedness of the Company or under any mortgage, indenture or
instrument under which there may be issued or by which there may be
secured or evidenced any Indebtedness of the Company (including the
notes), whether such Indebtedness exists at the time of the Indenture
or afterward, which constitutes a failure to pay an aggregate
principal amount exceeding $35,000,000 of Indebtedness when due and
payable after the expiration of any applicable grace period with
respect thereto and has resulted in such Indebtedness in an aggregate
principal amount exceeding $35,000,000 becoming or being declared due
and payable prior to the date on which it would otherwise have become
due and payable, without such Indebtedness having been discharged, or
such acceleration having been rescinded or annulled, within a period
of 10 days written notice (a Notice of Default) given to us by the
trustee or to us and the trustee as provided in the Indenture, unless
remedied, cured or waived as provided in the Indenture; and
(f) certain events of bankruptcy, insolvency or reorganization.
Subject to the provisions of the Indenture relating to the duties of the
trustee in case an Event of Default shall occur and be continuing, the trustee
will be under no obligation to exercise any of its rights or powers under the
Indenture at the request or direction of any of the holders, unless the holders
have offered to the trustee reasonable indemnity. Subject to these
indemnification provisions for the trustee, the holders of a majority in
aggregate principal amount of the outstanding notes will have the right to
direct the time, method and place of conducting any proceeding for any remedy
available to the trustee or exercising any trust or power conferred on the
trustee.
30
If an Event of Default (other than an Event of Default specified in
subsections (a), (b), and (f) above) occurs and is continuing, the trustee or
the holders of not less than 25% in principal amount of the outstanding notes
may declare the principal amount (or specified amount) of all the notes to be
due and payable immediately, by a notice in writing to us (and to the trustee if
given by holders), and upon any such declaration such principal and any accrued
interest and any unpaid liquidated damages on the notes will become immediately
due and payable. If an Event of Default specified in subsections (a) or (b)
occurs and is continuing, the holder of any outstanding note may, by notice in
writing to us (with a copy to the trustee), declare the principal of such note
to be due and payable immediately, and upon any such declaration the principal
and (subject to the Indenture) any accrued interest and liquidated damages on
such notes will become immediately due and payable. If an Event of Default
specified in subsection (f) occurs and is continuing, the principal and any
accrued interest, together with any liquidated damages thereon, on all of the
notes then outstanding shall become due and payable immediately without any
declaration or other Act on the part of the trustee or any holder.
At any time after a declaration of acceleration has been made but before a
judgment or decree based on acceleration, the holders of a majority in aggregate
principal amount of outstanding notes may, under certain circumstances, rescind
and annul such acceleration if all Events of Default, other than the nonpayment
of accelerated principal and interest have been cured or waived as provided in
the Indenture.
No holder of any note has any right to institute any proceeding with respect
to the Indenture or for any remedy thereunder, unless such holder shall have
previously given to the trustee written notice of a continuing Event of Default
and unless the holders of at least 25% in aggregate principal amount of the
outstanding notes also have made written request, and offered reasonable
indemnity, to the trustee to institute the proceeding as trustee, and the
trustee shall not have received from the holders of a majority in aggregate
principal amount of the outstanding notes a direction inconsistent with this
request and failed to institute the proceeding within 60 days. However, these
limitations do not apply to a suit instituted by a holder of a note for the
enforcement of payment of the principal of, premium, if any, or interest on that
note on or after the respective due dates expressed in that note or of the right
to convert that note in accordance with the Indenture.
We are required to furnish to the trustee annually a statement as to our
performance of certain of its obligations under the Indenture and as to any
default in such performance.
Modification and Waiver
The Indenture contains provisions permitting us and the trustee to enter into
a supplemental indenture without the consent of the holders,
(a) to evidence the succession of another Person to us and the
assumption by such successor of the covenants and obligations under
the Indenture and the notes,
(b) to add to the covenants for the benefit of the holders or to
surrender any right or power conferred upon us under the Indenture,
(c) to secure the notes,
(d) to modify the restrictions on, and procedures for, resale and other
transfers of the notes pursuant to law, regulation or practice
relating to the resale or transfer of restricted securities generally,
(e) to make provision with respect to the conversion rights of holders
pursuant to the Indenture,
(f) to accommodate the issuance of notes in book-entry or definitive
form and related matters not affecting adversely the interests of
the holders,
(g) to comply with the requirements of the SEC in order to effect and
maintain the qualification of the Indenture under the Trust
Indenture Act, or
(h) to cure any ambiguity or correct or supplement any provision of the
Indenture, provided that such action shall not adversely affect the
interests of the holders in any material respect.
31
In addition, modifications and amendments of the Indenture may be made, and
certain past defaults by the Company may be waived, with the written consent of
the holders of not less than a majority in aggregate principal amount of the
notes at the time outstanding (including consents obtained in connection with a
tender offer or exchange offer for the notes). However, no modification or
amendment may, without the consent of the holder of each outstanding note
affected thereby,
(a) change the Stated Maturity of the principal of, or any installment
of interest on, any note,
(b) reduce the principal amount of, or the premium, if any, or rate of
interest on, any note,
(c) reduce the amount payable upon redemption or repurchase,
(d) modify the provisions with respect to the repurchase right of the
holders in a manner adverse to the holders,
(e) change the coin or currency of payment of principal of, premium, if
any, or interest on, any note or coupon,
(f) impair the right to institute suit for the enforcement of any
payment on or with respect to any note or coupon,
(g) adversely affect the right to convert notes,
(h) reduce the above-stated percentage of outstanding notes necessary to
modify or amend the Indenture,
(i) reduce the percentage of aggregate principal amount of outstanding
notes necessary for waiver of compliance with certain provisions of
the Indenture or for waiver of certain defaults,
(j) reduce the percentage in aggregate principal amount of notes
outstanding required for the adoption of a Resolution or the quorum
required at any meeting of holders of notes at which a Resolution is
adopted, or
(k) modify our obligation to deliver information required under Rule 144A
to permit resales of notes and Common Stock issuable upon conversion
thereof in the event we cease to be subject to certain reporting
requirements under the U.S. securities laws.
The holders of a majority in aggregate principal amount of the outstanding
notes may waive our compliance with certain restrictive provisions of the
Indenture. The holders of a majority in aggregate principal amount of the
outstanding notes may waive any past default under the Indenture, except a
default in the payment of principal, premium, if any, or interest.
Transfer and Exchange
We have initially appointed the trustee as security registrar and transfer
agent, acting through its office or agency in the City of New York. We reserve
the right to vary or terminate the appointment of the security registrar or of
any transfer agent or to appoint additional or other transfer agents or to
approve any change in the office through which any security registrar or any
transfer agent acts.
A holder may transfer or exchange notes in accordance with the Indenture. The
registrar and the trustee may require a holder, among other things, to furnish
appropriate endorsements and transfers documents, and we may require a holder to
pay any taxes and fees required by law or permitted by the Indenture. We are not
required to transfer or exchange any note selected for redemption or repurchase.
Also, we are not required to transfer or exchange any note for a period of 15
days before a selection of notes is to be redeemed.
Purchase and Cancellation
We or any subsidiary may at any time and from time to time purchase notes at
any price in the open market or otherwise.
All Securities and coupons surrendered for payment, redemption, repurchase,
registration of transfer or exchange or conversion will, if surrendered to any
Person other than the trustee, be delivered to the trustee.
32
All Securities delivered to the trustee will be canceled promptly by the
trustee. No Securities will be authenticated in lieu of or in exchange for any
Securities canceled as provided in the Indenture. Unless otherwise requested by
us and confirmed in writing, the trustee will, from time to time but not less
than once annually, destroy all canceled Securities and coupons and deliver to
us a certificate of destruction, which certificate shall specify the number,
principal amount and, in the case of Securities, the form of each canceled
Security and coupon so destroyed.
Satisfaction and Discharge
The Indenture will cease to be of further effect with respect to the notes,
except as may otherwise be provided in the Indenture, if any time (i) we have
delivered to the trustee for cancellation all authenticated notes (other than
destroyed, lost or stolen notes and notes for whose payment trust funds have
been segregated and held in trust as provided in the Indenture) or (ii) all
notes not delivered to the trustee for cancellation have become due and payable,
or are by their terms to become due and payable within one year or are to be
called for redemption within one year under arrangements satisfactory to the
trustee for the giving of notice of redemption, and we deposit with the trustee
as trust funds, cash or government securities which through the payment of
principal and interest in accordance with their terms will provide money, in an
amount sufficient to pay the principal and any premium and interest on the notes
and all other sums payable by us under the indenture in connection with the
notes. This type of a trust may only be established if, among other things, we
have delivered to the trustee an opinion of counsel meeting the requirements set
forth in the Indenture.
Title
We and the trustee may treat the registered owner (as reflected in the
Security Register) of any note as the absolute owner thereof (whether or not
such note shall be overdue) for the purpose of making payment and for all other
purposes.
Notices
Notice to holders of the notes will be given by mail to the addresses of the
holders as they appear in the Security Register. Notices will be deemed to have
been given on the date of the first publication or on the date of mailing, as
the case may be.
Notice of a redemption of notes will be given at least once not less than 30
nor more than 60 days prior to the redemption date (which notice shall be
irrevocable) and will specify the redemption date.
Replacement of Notes
Notes that become mutilated, destroyed, stolen or lost will be replaced by us
at the expense of the holder upon delivery to the trustee or to a transfer agent
outside the United States of the mutilated notes or evidence of the loss, theft
or destruction thereof satisfactory to us and the trustee. In the case of a
lost, stolen or destroyed note indemnity satisfactory to the trustee and to us
may be required at the expense of the holder of such note before a replacement
note will be issued.
Payment of Stamp and Other Taxes
We will pay all stamp and other duties, if any, which may be imposed by the
United States or the United Kingdom or any political subdivision thereof or
taxing authority thereof or therein with respect to the issuance of the notes.
The Company will not be required to make any payment with respect to any other
tax, assessment or governmental charge imposed by any government or any
political subdivision thereof or taxing authority therein.
Governing Law
The Indenture and the notes are governed by and will be construed in
accordance with the laws of the State of New York.
33
The Trustee
The trustee for the holders of the notes issued under the Indenture is BNY
Midwest Trust Company.
In case an Event of Default occurs (and is not cured), the trustee will be
required to use the degree of care of a prudent person in the conduct of his own
affairs in the exercise of its powers. Subject to such provisions, the trustee
will be under no obligation to exercise any of its rights or powers under the
Indenture at the request of any of the holders of notes, unless they have
offered to the trustee reasonable security or indemnity.
Registration Rights
We entered into a registration rights agreement with the initial purchasers
of the notes. If you sell the notes or shares of Common Stock issued upon
conversion of the notes under this prospectus, you generally will be required to
be named as a selling security holder in this prospectus, deliver this
prospectus to purchasers and be bound by applicable provisions of the
registration rights agreement, including some indemnification provisions.
In the registration rights agreement, we agreed to use our best efforts to
keep the registration statement effective until the earlier of (1) two years
from the date of this prospectus; (2) the date when all of the notes covered by
the registration statement of which this prospectus forms a part have been sold
pursuant to the registration statement, transferred pursuant to Rule 144 under
the Securities Act or otherwise transferred in a manner that results in a new
security not subject to transfer restrictions under the Securities Act being
delivered pursuant to the Indenture; (3) the date when all of the shares of
Common Stock issuable upon conversion of the notes that have not previously been
sold pursuant to the registration statement of which this prospectus forms a
part have been sold pursuant to the registration statement, transferred pursuant
to Rule 144 under the Securities Act or otherwise transferred in a manner that
results in a new security not subject to transfer restrictions under the
Securities Act being delivered pursuant to the Indenture; and (4) the date when,
in the written opinion of independent counsel of Rite Aid, all outstanding notes
and shares of Common Stock issuable upon conversion of the notes that have not
previously been sold pursuant to the registration statement of which this
prospectus forms a part and that are held by persons who are not affiliates of
Rite Aid may be resold without registration under the Securities Act pursuant to
Rule 144(k) under the Securities Act, or any successor provision.
We may suspend the use of this prospectus under certain circumstances
relating to pending corporate developments, public filings with the SEC and
similar events for a period not to exceed an aggregate of 90 days in any 12-
month period. We also agreed to pay liquidated damages to holders of the notes
and shares of Common Stock issued upon conversion of the notes if this
registration statement is not timely filed or made effective or if the
prospectus is unavailable for periods in excess of those permitted above. You
should refer to the registration rights agreement for a description of these
liquidated damages.
34
DESCRIPTION OF CAPITAL STOCK
Our authorized capital stock consists of 1,000,000,000 shares of common stock
and 20,000,000 shares of preferred stock.
Common Stock
As of May 1, 2002, there were 515,113,894 shares of common stock issued
and outstanding.
The holders of common stock are entitled to receive ratably, from funds
legally available for the payment thereof, dividends when and as declared by
resolution of our Board of Directors, subject to any preferential dividend
rights granted to the holders of any outstanding preferred stock.
Each holder of common stock is entitled to one vote for such share registered
in his name and on our books on all matters submitted to a vote of security
holders. Except as otherwise provided by law, the holders of common stock vote
as one class. The shares of common stock do not have cumulative voting rights.
As a result, subject to the voting rights of the holders of any shares of our
preferred stock, including the voting rights of the Series D preferred stock,
which may at the time be outstanding, the holders of common stock entitled to
exercise more than 50% of the voting rights in an election of directors can
elect 100% of the directors to be elected in a particular year if they choose to
do so. In such event, the holders of the remaining common stock voting for the
election of directors will not be able to elect any persons to our Board of
Directors.
Holders of our common stock do not have preemptive, subscription, redemption
or conversion rights. The outstanding shares of common stock are duly
authorized, validly issued, fully paid and nonassessable.
Preferred Stock
Under the Rite Aid Charter, our Board has the authority, without further
security holder action, to issue from time to time up to a maximum of 20,000,000
shares of preferred stock, in one or more series and for such consideration as
may be fixed from time to time by the Board, and to fix before the issuance of
any shares of preferred stock of a particular series, the designation of such
series, the number of shares to comprise such series, the dividend rate or rates
payable with respect to the shares of such series, the redemption price or
prices, if any, and the terms and conditions of any redemption, the voting
rights, any sinking fund provisions for the redemption or purchase of the shares
of such series, the terms and conditions upon which the shares are convertible
or exchangeable, if they are convertible or exchangeable, and any other relative
rights, preferences and limitations pertaining to such series.
Series D Cumulative Convertible Pay-In-Kind Preferred Stock
As of May 1, 2002, there were 3,637,228 shares of Series D cumulative
pay-in-kind preferred stock outstanding. As of such date, the outstanding shares
of Series D preferred stock were convertible into 66,124,816 shares of our
common stock. The outstanding shares of Series D preferred stock are duly
authorized, validly issued, fully paid and nonassessable.
In the event of any voluntary or involuntary liquidation, dissolution or
winding up of us, holders of Series D preferred stock shall be entitled to
receive out of our assets legally available for distribution to security
holders, before any distribution of assets is made to holders of common stock or
any other class or series of capital stock ranking junior to Series D preferred
stock, a liquidation preference of $100, subject to certain adjustments, plus
all accrued and unpaid dividends thereon. If, upon any voluntary or involuntary
liquidation, dissolution or winding up of us, the amounts payable to holders of
Series D preferred stock and any other shares of preferred stock ranking as to
such distribution on a parity with the Series D preferred stock are not paid in
full, the holders of Series D preferred stock and of such other shares of
preferred stock will share ratably in any such distribution of our assets in
proportion to the full respective preferential amounts to which they are
entitled.
Each holder of Series D preferred stock is entitled to vote with holders of
common stock and each holder of Series D preferred stock is entitled to one vote
for each share of common stock issuable upon
35
conversion of such holder's Series D preferred stock. The holders of Series D
preferred stock are entitled to vote separately as a class to elect two
directors to our Board of Directors. Leonard I. Green and Jonathan D. Sokoloff
are the directors elected by the holders of Series D preferred stock.
Each share of Series D preferred stock is convertible into the number of
shares of our common stock equal to the liquidation preference divided by the
conversion price, which is $5.50 per share, subject to certain antidilution
adjustments. Without the prior consent of the holders of a majority of the
Series D preferred stock, we may not authorize, create or issue any securities
that are senior to the Series D preferred stock, or take certain other actions
that would adversely affect the rights, privileges and preferences of the Series
D preferred stock.
Each holder of Series D preferred stock is entitled to receive cumulative
preferential dividends at the rate of 8.0% on the liquidation preference,
payable quarterly in arrears. Dividends shall be paid, at our option, either in
cash, additional shares of Series D preferred stock, or a combination thereof.
From time to time, on or after October 25, 2004, we may redeem shares of Series
D preferred stock at 105% of the liquidation preference plus any unpaid partial
dividends to the applicable redemption date. Holders of Series D preferred stock
have no preemptive rights to subscribe for any additional securities we may
issue. We have granted the holders of Series D preferred stock certain
registration rights with respect to the Series D preferred stock and the common
stock into which the Series D preferred stock may be converted.
Charter and By-Law Provisions
The Rite Aid Charter specifies that our Board of Directors shall be divided
into three classes, as nearly equal in number as possible, and shall consist of
not less than three nor more than 15 directors elected for three-year staggered
terms. The term of one class of directors expires at each annual meeting of
security holders. Our By-laws provide that the number of directors on the Board
may be fixed by the Board only, or if the number is not fixed, the number will
be seven. The number of directors may be increased or decreased by the Board
only. In the interim period between annual meetings of security holders or of
special meetings of security holders, vacancies and newly created directorships
may be filled by the Board. Any directors so elected will hold office until the
next election of the class to which such directors have been elected. The Board
has been fixed at and currently consists of 9 directors.
The Rite Aid Charter requires that any mergers, consolidations, asset
dispositions and other transactions involving a beneficial owner of 10% or more
of the voting power of the then-outstanding classes of stock entitled to vote in
the election of directors be approved, unless certain conditions are satisfied,
by the affirmative vote of the holders of shares representing not less than 75%
of the voting stock. These special voting requirements do not apply if the
transaction is approved by a majority of the Continuing Directors (as defined
below) or the consideration offered to our security holders meets specified fair
price standards (including related procedural requirements as to the form of
consideration and continued payment of dividends). "Continuing Director" as
defined in the Rite Aid Charter means a member of our Board who was not
affiliated with a Related Person (as defined below) and was a member of the
Board prior to the time that the Related Person acquired the last shares of
common stock entitling such Related Person to exercise, in the aggregate, in
excess of 10% of the total voting power of all classes of voting stock, or any
individual, corporation, partnership, person or other entity ("Person")
recommended to succeed a Continuing Director by a majority of Continuing
Directors. "Related Person," as defined in the Rite Aid Charter, means any
Person or affiliate or associate of such Person, who has beneficial ownership
directly or indirectly of shares of stock of Rite Aid entitling such Person to
exercise more than 10% of the total voting power of all classes of voting stock.
The Rite Aid Charter also provides than any corporate action either (i) taken
at a special meeting of security holders called by the Board, a majority of
whose members are not Continuing Directors, or (ii) approved by written consent
of security holders, shall require the approval of not less than 75% of the
then-outstanding voting stock.
Under the Rite Aid Charter and By-laws, security holders may consent to any
action required or permitted to be taken at any meeting of security holders
without prior notice or a vote if a written consent or consents, setting forth
the action so taken, shall be signed by holders of outstanding stock having not
less
36
than the minimum number of votes that would be necessary to take the action at a
meeting at which all shares entitled to vote thereon were present and voted.
Change of Control
Section 203 of the Delaware General Corporation Law ("DGCL") generally
prohibits a Delaware corporation, including Rite Aid, from engaging in a
business combination (as defined below) with an interested security holder (as
defined below) for a period of three years after the time that such security
holder became an interested security holder, unless: (i) prior to such time, the
board of directors of the corporation approved either the business combination
or the transaction which resulted in the security holder becoming an interested
security holder; (ii) upon consummation of the transaction that resulted in the
security holder becoming an interested security holder, the interested security
holder owned at least 85% of the voting stock of the corporation outstanding at
the time the transaction commenced (excluding specified shares in determining
the number of voting stock outstanding); or (iii) at or after the time that such
security holder became an interested security holder, the board of directors of
the corporation approved and the shareholders authorized, at an annual or
special meeting by the affirmative vote of at least 66 2/3% of the outstanding
voting stock which is not owned by such interested security holder, the business
combination by means other than a written consent. A "business combination"
includes (i) mergers, consolidations and sales or other dispositions of 10% or
more of the assets of a corporation to or with an interested security holder,
(ii) certain transactions resulting in the issuance or transfer to an interested
security holder of any stock of such corporation or its subsidiaries, and (iii)
certain other transactions resulting in a financial benefit to an interested
security holder. An "interested security holder" means a person who owns (or, if
such person is an affiliate or associate of the corporation, within a three-year
period did own) 15% or more of a corporation's stock entitled to vote generally
in the election of directors and, the affiliates and associates of such person.
Indemnification of Officers and Directors
Under Section 145 of the DGCL, a corporation may indemnify any person who was
or is a party or is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation) by
reason of the fact that he or she is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him or her in connection with such action, suit or proceeding if he
or she (i) acted in good faith and in a manner he or she reasonably believed to
be in or not opposed to the best interests of the corporation and (ii) with
respect to any criminal action or proceeding, had no reasonable cause to believe
his or her conduct was unlawful. In actions by or in the right of the
corporation, the corporation may indemnify such person against expenses
(including attorneys' fees) actually and reasonably incurred by him or her in
connection with the defense or settlement of such action or suit if he or she
acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the best interests of the corporation; provided, however, no
indemnification may be made in respect of any claim, issue or matter as to which
he or she shall have been adjudged to be liable to the corporation unless and
only to the extent that the Court of Chancery of the State of Delaware or the
court in which such action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all circumstances of
the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper. To
the extent that a present or former director or officer of the corporation has
been successful on the merits or otherwise in defending any such action, suit or
proceeding referred to above or any claim, issue or matter therein, he or she is
entitled to indemnification against expenses (including attorneys' fees)
actually and reasonably incurred by him or her in connection therewith. The
indemnification and advancement of expenses provided by or granted pursuant to
Section 145 is not exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled, and a corporation
may purchase and maintain insurance against liabilities asserted against and
incurred by any former or current, director, officer, employee or agent of the
corporation, or a person who is or was serving at the request of the corporation
as a director, officer, employee or agent of
37
another corporation, partnership, joint venture, trust or other enterprise,
whether or not the power to indemnify is provided by the statute.
Article Tenth of our Certificate of Incorporation and Article VIII of our
By-laws provide for the indemnification of its directors and officers as
authorized by Section 145 of the DGCL.
Our and our subsidiaries' directors and officers are insured (subject to
certain exceptions and deductions) against liabilities which they may incur in
their capacity as such, including liabilities under the Securities Act, under
liability insurance policies carried by us.
38
CERTAIN UNITED STATES FEDERAL INCOME
TAX CONSIDERATIONS
General
This section summarizes certain U.S. federal income tax consequences to
holders of notes and the common stock issuable upon their conversion. However,
the discussion is limited in the following ways:
o The discussion covers you only if you hold your notes or the common stock
issuable upon their conversion as capital assets (that is, for investment
purposes), and if you do not have a special tax status. For example, this
discussion does not cover you if you are a bank, thrift, real estate
investment trust, regulated investment company, insurance company, dealer
in securities or currencies, tax-exempt investor, or if you hold your notes
or the common stock issuable upon their conversion as part of a hedge,
straddle, "synthetic security" or other integrated transaction for U.S.
federal income tax purposes, or if your functional currency is not the U.S.
dollar.
o The discussion does not cover tax consequences that depend upon your
particular tax situation.
o The discussion is based on current law. Changes in the law (including
possibly on a retroactive basis) may change the tax treatment of the notes
or the common stock issuable upon their conversion.
o The discussion does not cover any alternative minimum tax consequences,
U.S. federal estate or gift tax laws or the laws of any state, local or
foreign government that may be applicable to the notes or the common stock
issuable upon their conversion.
o We have not requested a ruling from the Internal Revenue Service ("IRS") on
the tax consequences of owning the notes or the common stock issuable upon
their conversion. As a result, the IRS could disagree with portions of this
discussion.
A "U.S. holder" is a citizen or resident of the United States or a domestic
corporation or a person who is otherwise subject to United States federal income
tax on a net income basis in respect of the notes or the common stock issuable
upon their conversion. All references to "holders" (including U.S. holders) are
to beneficial owners of the notes or the common stock issuable upon their
conversion.
The term "Non-U.S. holder" refers to any beneficial owner of notes or the
common stock issuable upon their conversion that is a nonresident alien or a
foreign corporation.
If a partnership, including any entity that is treated as a partnership for
U.S. federal income tax purposes, is a beneficial owner of notes or the common
stock issuable upon their conversion, the treatment of a partner in the
partnership will generally depend on the status of the partner and the
activities of the partnership.
If you are considering buying notes, we urge you to consult your tax advisor
about the particular federal, state, local and foreign tax consequences of the
acquisition, ownership and disposition of the notes, including the conversion of
the notes into common stock, and the application of the U.S. federal income tax
laws to your particular situation.
Registration of the Notes
The registration of the notes pursuant to this prospectus/registration statement
will not be a taxable event to holders of notes.
U. S. Holders
Taxation of Interest. U.S. holders will be required to recognize as ordinary
income any interest paid or accrued on the notes, in accordance with their
regular method of accounting for U.S. federal income tax purposes. In general,
if the terms of a debt instrument entitle a holder to receive payments other
than fixed periodic interest that exceed the issue price of the instrument, the
holder may be required to recognize additional interest as "original issue
discount" over the term of the instrument. We believe that the notes were not
issued with original issue discount.
39
Market Discount. If you purchase a note with "market discount," which
generally occurs when the purchase price for the note is less than the note's
principal amount, you will be subject to special rules. Under a de minimis
exception, however, those special rules will not apply if the amount of market
discount does not exceed one quarter of one percent for each full year remaining
until the maturity of the notes. If the special rules apply, any gain that you
recognize upon a sale or other disposition of the note will be treated as
ordinary income rather than capital gain to the extent of that portion of the
market discount that accrued prior to the disposition. Market discount generally
accrues on a straight line basis over the remaining term of the note, but you
can elect to compute accrued market discount based on the economic yield of the
note. If you hold a note with market discount you might be required to recognize
gain to the extent of accrued market discount even if your disposition of the
note takes a form, such as a gift, which would not normally result in the
recognition of gain. The market discount rules will not affect your tax
consequences upon conversion of the note, which will generally be nontaxable
under the rules described under "Conversion of Notes into our Common Stock." Any
market discount accrued prior to conversion, however, will be carried over to
the stock received on conversion, so that, to that extent, any gain recognized
by you upon disposition of the stock will be treated as ordinary interest
income. Finally, if your purchase of the notes is debt-financed, you will not be
entitled to deduct interest expense allocable to accrued market discount until
you recognize the corresponding interest income. You may elect to include the
market discount in income as it accrues. If you make this election, any gain
recognized on a disposition of the note will be entirely capital gain, and the
rules deferring the deduction of interest on related loans will not apply.
Acquisition Premium. If you purchase a note at a price that exceeds its
principal amount plus accrued interest, you can elect to amortize the premium as
a reduction to interest income so that the income reported by you each period
reflects your economic yield. Any premium paid on acquiring a note is not
amortizable, however, to the extent that it reflects the value of the conversion
privilege of the note. Once made, such an election is revocable only with IRS
consent. The election applies to all bonds, other than bonds the interest on
which is not includible in gross income, held by you at the beginning of the
first taxable year to which the election applies and all such bonds thereafter.
If you elect to amortize premium, the amortized premium that you acquire will
reduce your tax basis in the note.
Sale, Exchange or Redemption of Notes. On the sale, retirement or redemption
of your note:
o You will have taxable gain or loss equal to the difference between the
amount that you receive (to the extent such amount does not represent
accrued but unpaid interest (including accrued unrecognized market
discount), which will be treated as such) and your adjusted tax basis in
the note.
o Your gain or loss will be capital gain or loss, and will be long-term
capital gain or loss if you held the note for more than one year. For an
individual, the maximum tax rate on long-term capital gains is 20%.
Conversion of Notes into our Common Stock. If you convert your notes into
our common stock:
o You will not recognize gain or loss on the conversion of the notes into our
common stock, except if you receive cash in lieu of a fractional share.
o Your tax basis in our common stock received upon conversion of the notes
will be equal to your aggregate tax basis in the notes converted, less any
portion allocable to cash received in lieu of a fractional share.
o The holding period of the common stock you receive upon conversion of notes
generally will include the period during which you held the notes prior to
the conversion.
o The amount of any accrued market discount that you did not previously
include in income with respect to a converted note will be treated as
ordinary income when you dispose of our common stock.
o Cash received in lieu of a fractional share of common stock should be
treated as a payment in exchange for the fractional share (rather than as a
dividend). Gain or loss recognized on the receipt of cash paid in lieu of
the fractional share should equal the difference between the amount of cash
received for the fractional share and your tax basis allocable to the
fractional share exchanged. Any such gain or loss will be capital gain or
loss, and generally will be long-term capital gain or loss if you held the
notes for more than one year at the time of conversion.
Distributions on our Common Stock. Distributions on our common stock will
constitute dividends for U.S. federal income tax purposes to the extent of our
current or accumulated earnings and profits as determined under U.S. federal
income tax principles. If you are a U.S. corporation, dividends paid to you
may qualify for the dividends-received deduction.
To the extent that you receive distributions on our common stock that would
otherwise constitute dividends for U.S. federal income tax purposes but that
exceed our current and accumulated earnings and profits, the distribution will
be treated first as a non-taxable return of capital, which reduces your basis in
the common stock. Any distribution in excess of your basis in the common stock
will be treated as capital gain.
Deemed Distributions. The conversion rate of the notes is subject to
adjustment under certain circumstances, as described under "Description of
Notes--Conversion Rights." Certain adjustments to the conversion rate may cause
you to be treated as having received a distribution. For example, an increase in
the conversion rate of the notes in the event of a distribution of our evidences
of indebtedness to holders of our common stock or in the event of an
extraordinary cash dividend generally will result in a deemed distribution to
U.S. holders of notes. Such a distribution would be taxable to you as a
dividend, return of capital or capital gain in accordance with the earnings and
profits rules discussed above under "--U.S. Holders-- Distributions on our
Common Stock."
Sale or Exchange of Common Stock. If you sell or exchange your shares of our
common stock, you will recognize gain or loss equal to the difference between
the amount realized on the sale or exchange and your adjusted tax basis in those
shares. Any such gain or loss will generally be long-term capital gain or loss
if you have held or are deemed to have held the shares of common stock for more
than one year. Any such gain will be treated as ordinary interest income,
however, to the extent that it is attributable to accrued but unrecognized
market discount that was carried over to such stock upon your conversion of a
note.
40
Non-U.S. Holders
Withholding Tax on Payments of Principal and Interest on Notes. Generally,
payments of principal and interest on a note will not be subject to U.S.
federal withholding tax, provided that in the case of an interest payment:
o You do not actually or constructively own 10% or more of the total combined
voting power of all our voting stock;
o you are not a controlled foreign corporation that is related to us within
the meaning of U.S. federal income tax laws; and
o you are either (A) the beneficial owner of the note and you certify to the
applicable payor or its agent, under penalties of perjury, that you are not
a United States person and provide your name and address on an IRS Form
W-8BEN (or a suitable substitute form), or (B) a securities clearing
organization, bank or other financial institution that holds customers'
securities in the ordinary course of your trade or business (a "financial
institution") and hold notes, and you certify under penalties of perjury
that such an IRS Form W-8BEN (or suitable substitute form) has been
received from the beneficial owner or by a financial institution between it
and the beneficial owner and you furnish the payor with a copy thereof,
unless in each case the payor or agent knows or has reason to know that you
are not entitled to an exemption.
Additional exemptions may apply to holders who hold their notes through
"qualified intermediaries" within the meaning of U.S. federal income tax laws.
Except to the extent otherwise provided under an applicable tax treaty, you
generally will be taxed in the same manner as a U.S. holder with respect to
interest payments on a note (but will be exempt from U.S. federal withholding
tax) if such interest is effectively connected with your conduct of a trade or
business in the United States and you complete IRS Form W-8ECI.
Dividends. Dividends, if any, paid on the common stock to you, and any deemed
dividends resulting from an adjustment to the conversion price (see "-- U.S.
Holders--Deemed Distributions" above), generally will be subject to a 30% U.S.
federal withholding tax, subject to reduction if you are eligible for the
benefits of an applicable income tax treaty. You will be required to file an IRS
Form W-8BEN to claim tax treaty benefits. However, except to the extent
otherwise provided under an applicable tax treaty, you generally will be taxed
in the same manner as a U.S. holder on dividends paid (or deemed paid) that are
effectively connected with your conduct of a trade of business in the United
States. You will not be entitled to a reduction in or an exemption from U.S.
federal withholding tax if the payor or agent knows or has reason to know that
you are not entitled to a reduction or exemption.
Gain on Disposition of the Notes and Common Stock. You generally will not be
subject to U.S. federal income tax on gain realized on the sale, exchange or
redemption of a note, or the sale or exchange of our common stock unless:
o you are an individual present in the United States for 183 days or more in
the year of such sale, exchange or redemption and certain other
requirements are met;
o the income or gain is "U.S. trade or business income," which means income
or gain that is effectively connected with your conduct of a trade or
business in the United States or, if you are a treaty resident,
attributable to a permanent establishment or a fixed base in the United
States; or
o you are subject to the provisions of U.S. tax law applicable to certain
United States expatriates.
Backup Withholding and Information Reporting
U.S. Holders. Payments of interest or dividends, if any, made by us on, or
the proceeds of the sale or other disposition of, the notes or shares of common
stock may be subject to information reporting, and U.S. federal backup
withholding tax at the applicable rate if the recipient of such payment fails to
supply a taxpayer identification number, certified under penalties of perjury,
as well as certain other information or otherwise establishes an exemption from
backup withholding. Any amounts withheld under the
41
backup withholding rules may be allowed as a refund or a credit against that
holder's U.S. federal income tax liability provided the required information
is furnished to the IRS.
Non-U.S. Holders. A Non-U.S. holder may be required to comply with
certification procedures to establish that the holder is not a U.S. person in
order to avoid backup withholding tax with respect to our payment of principal
and interest on the notes, or the proceeds of the sale or other disposition of
the notes. In addition, we must report annually to the IRS and to each Non-
U.S. holder the amount of any dividends paid to and the tax withheld (if any)
with respect to such Non-U.S. holder. Copies of these information returns may
also be made available under the provisions of a specific treaty or agreement
to the tax authorities of the country in which the Non-U.S. holder resides.
42
PLAN OF DISTRIBUTION
The selling security holders will be offering and selling all of the
securities offered and sold under this prospectus. We will not receive any of
the proceeds from the offering of the notes or the shares of common stock by the
selling security holders. In connection with the initial offering of the notes,
we entered into a registration rights agreement dated as of November 19, 2001
with the initial purchasers of the notes. Securities may only be offered or sold
under this prospectus pursuant to the terms of the registration rights
agreement.
However, selling security holders may resell all or a portion of the
securities in open market transactions in reliance upon Rule 144 or Rule 144A
under the Securities Act, provided they meet the criteria and conform to the
requirements of one of these rules. We are registering the notes and shares of
common stock covered by this prospectus to permit holders to conduct public
secondary trading of these securities from time to time after the date of this
prospectus. We have agreed, among other things, to bear all expenses, other than
underwriting discounts and selling commissions, in connection with the
registration and sale of the notes and the shares of common stock covered by
this prospectus.
The selling security holders may sell all or a portion of the notes and
shares of common stock beneficially owned by them and offered hereby from time
to time:
o directly; or
o through underwriters, broker-dealers or agents, who may receive
compensation in the form of discounts, commissions or concessions from the
selling security holders and/or from the purchasers of the notes and shares
of common stock for whom they may act as agent.
The notes and the shares of common stock may be sold from time to time in one
or more transactions at:
o fixed prices, which may be changed;
o prevailing market prices at the time of sale;
o varying prices determined at the time of sale; or
o negotiated prices.
These prices will be determined by the holders of the securities or by
agreement between these holders and underwriters or dealers who may receive fees
or commissions in connection with the sale. The aggregate proceeds to the
selling security holders from the sale of the notes or shares of common stock
offered by them hereby will be the purchase price of the notes or shares of
common stock less discounts and commissions, if any.
The sales described in the preceding paragraph may be effected in
transactions:
o on any national securities exchange or quotation service on which the notes
or shares of common stock may be listed or quoted at the time of sale,
including the New York Stock Exchange in the case of the shares of common
stock;
o in the over-the counter market;
o in transactions otherwise than on such exchanges or services or in the
over-the-counter market; or
o through the writing of options.
These transactions may include block transactions or crosses. Crosses are
transactions in which the same broker acts as an agent on both sides of the
trade.
In connection with sales of the notes and shares of common stock or
otherwise, the selling security holders may enter into hedging transactions with
broker-dealers. These broker-dealers may in turn engage in short sales of the
notes and shares of common stock, short and deliver notes and shares of common
stock to close out such short positions, or loan or pledge notes and shares of
common stock to broker-dealers that may in turn sell such securities. The
selling security holders may pledge or grant a security interest in some or all
43
of the notes and shares of common stock that it owns and, if it defaults in the
performance of its secured obligations, the pledgees or secured parties may
offer and sell the notes and shares of common stock from time to time pursuant
to this prospectus. The selling security holders may also transfer and donate
notes and shares of common stock in other circumstances, in which case the
transferees, donees, pledgees or other successors in interest will be selling
security holders for the purposes of this prospectus.
To our knowledge, there are currently no plans, arrangements or
understandings between any selling security holders and any underwriter,
broker-dealer or agent regarding the sale of the notes and the shares of common
stock by the selling security holders. Selling security holders may not sell
any, or may not sell all, of the notes and the shares of common stock offered by
them pursuant to this prospectus. In addition, we cannot assure you that a
selling security holder will not transfer, devise or gift the notes and the
shares of common stock by means other than those described in this prospectus.
In addition, any securities covered by this prospectus which qualify for sale
pursuant to Rule 144 or Rule 144A of the Securities Act may be sold under Rule
144 or Rule 144A rather than pursuant to this prospectus.
The notes were issued and sold in November 2001 in transactions exempt from
the registration requirements of the Securities Act pursuant to Rule 144A under
the Securities Act or in offshore transactions pursuant to Regulation S under
the Securities Act. Pursuant to the registration rights agreement, we have
agreed to indemnify the initial purchasers, each selling security holder and
certain underwriters, and each selling security holder has agreed to indemnify
us, the initial purchasers, certain underwriters and the other selling security
holders, against specified liabilities arising under the Securities Act.
The selling security holders and any other person participating in such
distribution will be subject to the Exchange Act. The Exchange Act rules
include, without limitation, Regulation M, which may limit the timing of
purchases and sales of any of the notes and the underlying shares of common
stock by the selling security holders and any such other person. In addition,
Regulation M of the Exchange Act may restrict the ability of any person engaged
in the distribution of the notes and the underlying shares of common stock to
engage in market-making activities with respect to the particular notes and the
underlying shares of common stock being distributed for a period of up to five
business days prior to the commencement of distribution. This may affect the
marketability of the notes and the underlying shares of common stock and the
ability of any person or entity to engage in market-making activities with
respect to the notes and the underlying shares of common stock.
Under the registration rights agreement, we are obligated to use best efforts
to keep the registration statement of which this prospectus forms a part
effective until the earlier of:
o two years from the date of this prospectus;
o the date when all of the notes covered by the registration statement of
which this prospectus forms a part have been sold pursuant to the
registration statement, transferred pursuant to Rule 144 under the
Securities Act or otherwise transferred in a manner that results in a new
security not subject to transfer restrictions under the Securities Act
being delivered pursuant to the Indenture;
o the date when all of the shares of common stock issuable upon conversion of
the notes that have not been previously sold pursuant to the registration
statement of which this prospectus forms a part have been sold pursuant to
the registration statement, transferred pursuant to Rule 144 under the
Securities Act or otherwise transferred in a manner that results in a new
security not subject to transfer restrictions under the Securities Act
being delivered pursuant to the Indenture; and
o the date when, in the written opinion of independent counsel of Rite Aid,
all outstanding notes and shares of common stock issuable upon conversion
of the notes that have not been previously sold pursuant to the
registration statement of which this prospectus forms a part and that are
held by persons who are not affiliates of Rite Aid may be resold without
registration under the Securities Act pursuant to Rule 144(k) under the
Securities Act, or any successor provision.
44
Our obligation to keep the registration statement to which this prospectus
relates effective is subject to specified, permitted exceptions set forth in the
registration rights agreement. In these cases, we may prohibit offers and sales
of the notes and shares of common stock pursuant to the registration statement
to which this prospectus relates.
We may suspend the use of this prospectus if we learn of any event that
causes this prospectus to include an untrue statement of a material fact
required to be stated in the prospectus or necessary to make the statements in
the prospectus not misleading in light of the circumstances then existing. If
this type of event occurs, a prospectus supplement or post-effective amendment,
if required, will be distributed to each selling security holder. Each selling
security holder has agreed not to trade securities from the time the selling
security holder receives notice from us of this type of event until the selling
security holder receives a prospectus supplement or amendment. This time period
will not exceed an aggregate of ninety days in any twelve-month period.
LEGAL MATTERS
Certain legal matters as to the validity of the shares offered by this
prospectus will be passed upon for us by Skadden, Arps, Slate, Meagher & Flom
LLP, New York, New York. Nancy A. Lieberman, a partner of Skadden, Arps, Slate,
Meagher & Flom LLP, is a director and security holder of Rite Aid.
EXPERTS
The consolidated financial statements and related financial statement
schedule of the Company and its consolidated subsidiaries, except PCS Holding
Corporation and subsidiaries which has been included in discontinued operations
in such consolidated financial statements, as of March 2, 2002 and March 3,
2001, and for each of the three years in the period ended March 2, 2002
incorporated in this prospectus by reference from our Annual Report on Form 10-K
for the year ended March 2, 2002 have been audited by Deloitte & Touche LLP,
independent auditors, as stated in their reports, which are incorporated by
reference and have been so incorporated in reliance upon the report of such firm
given upon their authority as experts in accounting and auditing.
The financial statements of PCS Holding Corporation and subsidiaries
for the year ended February 26, 2000, not separately included herein or
elsewhere in the registration statement have been audited by Ernst & Young, LLP,
independent auditors, as stated in their report, which is incorporated by
reference herein. Such financial statements are incorporated by reference herein
in reliance upon the report of such firm given upon their authority as experts
in accounting and auditing.
45
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
The following table sets forth the costs and expenses, other than
underwriting discounts and commissions, to be paid in connection with the sale
of the common stock being registered, all of which will be paid by the
registrant. All amounts are estimates except the registration fee.
SEC registration fee ............................................ $ 23,000
Accounting fees and expenses .................................... $ 50,000
Legal fees and expenses ......................................... $150,000
Printing fees ................................................... $ 75,000
Miscellaneous ................................................... $ 25,000
--------
Total ........................................................... $323,000
========
Item 15. Indemnification of Officers and Directors
Under Section 145 of the DGCL, a corporation may indemnify any person who was
or is a party or is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation) by
reason of the fact that he or she is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, against expenses (including attorneys'
fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by him or her in connection with such action, suit or proceeding if he
or she (i) acted in good faith and in a manner he or she reasonably believed to
be in or not opposed to the best interests of the corporation and (ii) with
respect to any criminal action or proceeding, had no reasonable cause to believe
his or her conduct was unlawful. In actions by or in the right of the
corporation, the corporation may indemnify such person against expenses
(including attorneys' fees) actually and reasonably incurred by him or her in
connection with the defense or settlement of such action or suit if he or she
acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the best interests of the corporation; provided, however, no
indemnification may be made in respect of any claim, issue or matter as to which
he or she shall have been adjudged to be liable to the corporation unless and
only to the extent that the Court of Chancery of the State of Delaware or the
court in which such action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all circumstances of
the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper. To
the extent that a present or former director or officer of the corporation has
been successful on the merits or otherwise in defending any such action, suit or
proceeding referred to above or any claim, issue or matter therein, he or she is
entitled to indemnification against expenses (including attorneys' fees)
actually and reasonably incurred by him or her in connection therewith. The
indemnification and advancement of expenses provided by or granted pursuant to
Section 145 is not exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled, and a corporation
may purchase and maintain insurance against liabilities asserted against and
incurred by any former or current, director, officer, employee or agent of the
corporation, or a person who is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise, whether or not the power to indemnify
is provided by the statute.
Article Tenth of our Certificate of Incorporation and Article VIII of our
By-laws provide for the indemnification of its directors and officers as
authorized by Section 145 of the DGCL.
Our and our subsidiaries' directors and officers are insured (subject to
certain exceptions and deductions) against liabilities which they may incur in
their capacity as such, including liabilities under the Securities Act, under
liability insurance policies carried by us.
II-1
Item 16. Exhibits
Exhibit Incorporation by
Numbers Description Reference to
------- ----------- ------------
4.1 Indenture, dated as of September 10, 1997, between Exhibit 4.1 to Registration Statement
Rite Aid Corporation, as issuer, and Harris Trust and on Form S-3, File No. 333-39699, filed
Savings Bank, as trustee, related to the Company's on November 6, 1997
5.25% Convertible Subordinated Notes due 2002
4.2 Indenture, dated as of September 22, 1998, between Exhibit 4.1 to Registration Statement
Rite Aid Corporation, as issuer, and Harris Trust and on Form S-4, File No. 333-66901, filed
Savings Bank, as trustee, related to the Company's 6% on November 6, 1998
Dealer Remarketable Securities
4.3 Indenture, dated as of December 21, 1998, between Rite Exhibit 4.1 to Registration Statement
Aid Corporation, as issuer, and Harris Trust and on Form S-4, File No. 333-74751, filed
Savings Bank, as trustee, related to the Company's 5 on March 19, 1999
1/2% Notes due 2000, 6% Notes due 2005, 6 1/8% Notes
due 2008 and 6 7/8% Notes due 2028
4.4 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.1 to Form 8-K, filed on
between Rite Aid Corporation and U.S. Bank Trust February 7, 2000
National Association to the Indenture, dated as of
August 1, 1993, between Rite Aid Corporation and
Morgan Guaranty Trust Company of New York, related to
the Company's 6.70% Notes due 2001, 7.125% Notes due
2007, 7.70% Notes due 2027, 7.625% Notes due 2005 and
6.875% Senior Debentures due 2013
4.5 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.2 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of September
10, 1997, between Rite Aid Corporation and Harris
Trust and Savings Bank, related to the Company's 5.25%
Convertible Subordinated Notes due 2002
4.6 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.3 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of September
22, 1998, between Rite Aid Corporation and Harris
Trust and Savings Bank, related to the Company's 6%
Dealer Remarketable Securities
4.7 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.4 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of December
21, 1998, between Rite Aid Corporation and Harris
Trust and Savings Bank, related to the Company's 5.5%
Notes due 2000, 6% Notes due 2005, 6.125% Notes due
2008 and 6.875% Notes due 2008
4.8 Indenture, dated as of June 14, 2000, among Rite Aid Exhibit 4.1 to Form 8-K, filed on June
Corporation, as issuer, each of the Subsidiary 21, 2000
Guarantors named therein and State Street Bank and
Trust Company, as trustee, related to the Company's
10.5% Senior Secured Notes due 2002
II-2
Exhibit Incorporation by
Numbers Description Reference to
------- ----------- ------------
4.9 Exchange and Registration Rights Agreement, dated as Exhibit 4.2 to Form 8-K, filed on June
of June 14, 2000, by and among Rite Aid Corporation, 21, 2000
State Street Bank and Trust Company and the Holders of
the 10.50% Senior Secured Notes due 2002
4.10 Registration Rights Agreement, dated as of June 14, Exhibit 4.3 to Form 8-K, filed on June
2000, by and among Rite Aid Corporation and the 21, 2000
Lenders listed therein
4.11 Indenture, dated as of June 27, 2001, among Rite Aid Exhibit 4.7 to Registration Statement
Corporation, as issuer, each of the Subsidiary on Form S-1, File No. 333-64950, filed
Guarantors named therein and State Street Bank and on July 12, 2001
Trust Company, as trustee, related to the Company's
12.50% Senior Secured Notes due 2006
4.12 Indenture, dated as of June 27, 2001, between Rite Aid Exhibit 4.8 to Registration Statement
Corporation, as issuer, and BNY Midwest Trust Company, on Form S-1, File No. 333-64950, filed
as trustee, related to the Company's 11 1/4% Notes due on July 12, 2001
2008
4.13 Exchange and Registration Rights Agreement, dated as Exhibit 4.9 to Registration Statement
of June 27, 2001, between Rite Aid Corporation and on Form S-1, File No. 333-64950, filed
Salomon Smith Barney Inc., Credit Suisse First Boston on July 12, 2001
Corporation, J.P. Morgan Securities Inc. and Fleet
Securities, Inc., as initial purchasers, for the
benefit of the holders of the Company's 11 1/4% Notes
due 2008
4.14 Indenture, dated as of November 19, 2001, between Rite Exhibit 4.3 to Quarterly Report on
Aid Corporation, as issuer, and BNY Midwest Trust Form 10-Q, filed on January 15, 2002
Company, as trustee, related to the Company's 4.75%
Convertible Notes due 2006
4.15 Registration Rights Agreement, dated as of November Exhibit 4.4 to Quarterly Report on
19, 2001, between the Company and Salomon Smith Barney Form 10-Q, filed on January 15, 2002
Inc. and J.P. Morgan Securities Inc., as initial
purchasers, for the benefit of the holders of the
Company's 4.75% Convertible Notes due 2006
4.16 Indenture, dated as of April 4, 2002, between Rite Aid Exhibit T3C to Form T-3, filed on
Corporation, as issuer, and BNY Midwest Trust Company, March 4, 2002
as trustee, related to the Company's Senior Secured
Notes due 2006
5 Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Filed herewith
12 Statement regarding computation of ratio of earnings Exhibit 12 to Annual Report on Form
to fixed charges 10-K, filed on May 7, 2002
23.1 Independent Auditors' Consent Filed herewith
23.2 Independent Auditors' Consent Filed herewith
23.3 Consent of Skadden, Arps, Slate, Meagher & Flom LLP Filed herewith
(included in Exhibit 5)
24 Power of Attorney Signature pages to Registration
Statement on Form S-3, File No. 333-
82872, filed on February 15, 2002
25 Statement of Eligibility of Trustee Previously filed as Exhibit 25 to
Registration Statement on Form S-3,
File No. 333-82872, filed on
February 15, 2002
II-3
Item 17. Undertakings
Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant
has been advised that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:
(i) To include any prospectus required by section 10(a)(3) of the
Securities Act;
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the Registration Statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of
prospectus filed with the SEC pursuant to Rule 424(b) of the
Securities Act if, in the aggregate, the changes in volume and price
represent no more than a 20% change in the maximum aggregate offering
price set forth in the "Calculation of Registration Fee" table in the
effective Registration Statement; and
(iii)To include any material information with respect to the plan of
distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration
Statement;
provided, however, paragraphs (1)(a) and (1)(b) shall not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
SEC by the Registrant pursuant to Section 13 or Section 15(d) of the
Exchange Act that are incorporated by reference in the Registration
Statement.
(2) That, for the purpose of determining any liability under the Securities
Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.
The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
Registrant's annual report pursuant to section 13(a) or section 15(d) of the
Exchange Act (and, where applicable, each filing of an associate benefit plan's
annual report pursuant to section 15(d) of the Exchange Act) that is
incorporated by reference in the Registration Statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Camp Hill, State of
Pennsylvania, on May 14, 2002.
RITE AID CORPORATION
By: /s/ ROBERT G. MILLER
----------------------------------------------
Robert G. Miller
Chairman of the Board
and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed by the following persons in the capacities and on the
dates indicated.
Signature Title Date
--------- ----- ----
*/s/ ROBERT G. MILLER Chairman of the Board and May 14, 2002
-------------------------------------- Chief Executive Officer
Robert G. Miller
*/s/ MARY F. SAMMONS President, Chief Operating May 14, 2002
-------------------------------------- Officer and Director
Mary F. Sammons
*/s/ JOHN T. STANDLEY Chief Financial Officer and Senior May 14, 2002
-------------------------------------- Executive Vice President
John T. Standley
*/s/ KEVIN J. TWOMEY Chief Accounting Officer and May 14, 2002
-------------------------------------- Senior Vice President
Kevin J. Twomey
II-5
Signature Title Date
--------- ----- ----
*/s/ WILLIAM J. BRATTON Director May 14, 2002
--------------------------------------
William J. Bratton
*/s/ ALFRED M. GLEASON Director May 14, 2002
--------------------------------------
Alfred M. Gleason
/s/ GEORGE G. GOLLEHER Director May 14, 2002
--------------------------------------
George G. Golleher
*/s/ LEONARD I. GREEN Director May 14, 2002
--------------------------------------
Leonard I. Green
*/s/ NANCY A. LIEBERMAN Director May 14, 2002
--------------------------------------
Nancy A. Lieberman
*/s/ STUART M. SLOAN Director May 14, 2002
--------------------------------------
Stuart M. Sloan
*/s/ JONATHAN D. SOKOLOFF Director May 14, 2002
--------------------------------------
Jonathan D. Sokoloff
*By: /s/ KEVIN J. TWOMEY
------------------------------------
Kevin J. Twomey
Attorney-in-fact
II-6
EXHIBIT INDEX
Exhibit Incorporation by
Numbers Description Reference to
-------- ----------- ------------
4.1 Indenture, dated as of September 10, 1997, between Rite Exhibit 4.1 to Registration Statement
Aid Corporation, as issuer, and Harris Trust and Savings on Form S-3, File No. 333-39699, filed
Bank, as trustee, related to the Company's 5.25% on November 6, 1997
Convertible Subordinated Notes due 2002
4.2 Indenture, dated as of September 22, 1998, between Rite Exhibit 4.1 to Registration Statement
Aid Corporation, as issuer, and Harris Trust and Savings on Form S-4, File No. 333-66901, filed
Bank, as trustee, related to the Company's 6% Dealer on November 6, 1998
Remarketable Securities
4.3 Indenture, dated as of December 21, 1998, between Rite Exhibit 4.1 to Registration Statement
Aid Corporation, as issuer, and Harris Trust and Savings on Form S-4, File No. 333-74751, filed
Bank, as trustee, related to the Company's 5 1/2% Notes on March 19, 1999
due 2000, 6% Notes due 2005, 6 1/8% Notes due 2008 and 6
7/8% Notes due 2028
4.4 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.1 to Form 8-K, filed on
between Rite Aid Corporation and U.S. Bank Trust February 7, 2000
National Association to the Indenture, dated as of
August 1, 1993, between Rite Aid Corporation and Morgan
Guaranty Trust Company of New York, related to the
Company's 6.70% Notes due 2001, 7.125% Notes due 2007,
7.70% Notes due 2027, 7.625% Notes due 2005 and 6.875%
Senior Debentures due 2013
4.5 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.2 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of September 10,
1997, between Rite Aid Corporation and Harris Trust and
Savings Bank, related to the Company's 5.25% Convertible
Subordinated Notes due 2002
4.6 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.3 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of September 22,
1998, between Rite Aid Corporation and Harris Trust and
Savings Bank, related to the Company's 6% Dealer
Remarketable Securities
4.7 Supplemental Indenture, dated as of February 3, 2000, Exhibit 4.4 to Form 8-K, filed on
between Rite Aid Corporation and Harris Trust and February 7, 2000
Savings Bank to the Indenture, dated as of December 21,
1998, between Rite Aid Corporation and Harris Trust and
Savings Bank, related to the Company's 5.5% Notes due
2000, 6% Notes due 2005, 6.125% Notes due 2008 and
6.875% Notes due 2008
4.8 Indenture, dated as of June 14, 2000, among Rite Aid Exhibit 4.1 to Form 8-K, filed on June
Corporation, as issuer, each of the Subsidiary 21, 2000
Guarantors named therein and State Street Bank and Trust
Company, as trustee, related to the Company's 10.5%
Senior Secured Notes due 2002
Exhibit Incorporation by
Numbers Description Reference to
-------- ----------- ------------
4.9 Exchange and Registration Rights Agreement, dated as of Exhibit 4.2 to Form 8-K, filed on June
June 14, 2000, by and among Rite Aid Corporation, State 21, 2000
Street Bank and Trust Company and the Holders of the
10.50% Senior Secured Notes due 2002
4.10 Registration Rights Agreement, dated as of June 14, Exhibit 4.3 to Form 8-K, filed on June
2000, by and among Rite Aid Corporation and the Lenders 21, 2000
listed therein
4.11 Indenture, dated as of June 27, 2001, among Rite Aid Exhibit 4.7 to Registration Statement
Corporation, as issuer, each of the Subsidiary on Form S-1, File No. 333-64950, filed
Guarantors named therein and State Street Bank and Trust on July 12, 2001
Company, as trustee, related to the Company's 12.50%
Senior Secured Notes due 2006
4.12 Indenture, dated as of June 27, 2001, between Rite Aid Exhibit 4.8 to Registration Statement
Corporation, as issuer, and BNY Midwest Trust Company, on Form S-1, File No. 333-64950, filed
as trustee, related to the Company's 11 1/4% Notes due on July 12, 2001
2008
4.13 Exchange and Registration Rights Agreement, dated as of Exhibit 4.9 to Registration Statement
June 27, 2001, between Rite Aid Corporation and Salomon on Form S-1, File No. 333-64950, filed
Smith Barney Inc., Credit Suisse First Boston on July 12, 2001
Corporation, J.P. Morgan Securities Inc. and Fleet
Securities, Inc., as initial purchasers, for the benefit
of the holders of the Company's 11 1/4% Notes due 2008
4.14 Indenture, dated as of November 19, 2001, between Rite Exhibit 4.3 to Quarterly Report on
Aid Corporation, as issuer, and BNY Midwest Trust Form 10-Q, filed on January 15, 2002
Company, as trustee, related to the Company's 4.75%
Convertible Notes due 2006
4.15 Registration Rights Agreement, dated as of November 19, Exhibit 4.4 to Quarterly Report on
2001, between the Company and Salomon Smith Barney Inc. Form 10-Q, filed on January 15, 2002
and J.P. Morgan Securities Inc., as initial purchasers,
for the benefit of the holders of the Company's 4.75%
Convertible Notes due 2006
4.16 Indenture, dated as of April 4, 2002, between Rite Aid Exhibit T3C to Form T-3, filed on
Corporation, as issuer, and BNY Midwest Trust Company, March 4, 2002
as trustee, related to the Company's Senior Secured
Notes due 2006
5 Opinion of Skadden, Arps, Slate, Meagher & Flom LLP Filed herewith
12 Statement regarding computation of ratio of earnings to Exhibit 12 to Annual Report on Form
fixed charges 10-K, filed on May 7, 2002
23.1 Independent Auditors' Consent Filed herewith
23.2 Independent Auditors' Consent Filed herewith
23.3 Consent of Skadden, Arps, Slate, Meagher & Flom LLP Filed herewith
(included in Exhibit 5)
24 Power of Attorney Signature pages to Registration
Statement on Form S-3, File No. 333-
82872, filed on February 15, 2002
25 Statement of Eligibility of Trustee Previously filed as Exhibit 25 to
Registration Statement on Form S-3,
File No. 333-82872, filed on
February 15, 2002